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REFERENCES
SUMMARY
A generation of schizophrenic patients has grown up since the introduction in the 
1950's of community care and antipsychotic medication, and over the past two decades 
many have been exposed to long term maintenance antipsychotic drug treatment. 
However, there have been very few studies describing the impact of these 
developments on a community of schizophrenic patients. The Nithsdale surveys over a 
10 year period have tried to do this. The studies fall into three broad groups: the mental 
state, behaviour and social adjustment of the patient; the family life of the patient, with 
special reference to relatives' expressed emotion; and the motor disorders produced by 
antipsychotic medication. Most recently, the frequency of obstetric complications in 
schizophrenic patients has been examined.
THE PATIENT
The first census in 1981 of all known schizophrenic patients in Nithsdale, Dumfries and 
Galloway Region, Scotland identified 133 patients, a point prevalence of 2.38 per
1,000 of the total population. Only three percent of the cohort had no abnormality in 
mental state or behaviour; negative schizophrenic symptoms were prominent. Only 
one quarter were inpatients. Patients' and their relatives' assessment of the patient's 
overall social adjustment correlated very closely, thus suggesting a schizophrenic 
patient can satisfactorily describe his own adjustment. The patients were less well 
adjusted than a normal community population in all areas except the parental role.
FAMILY LIFE
A repeat census in 1985 found that 50 percent of patients were living with relatives or 
friends. The family atmosphere, that is, the relatives' level of expressed emotion (EE), 
was assessed through the Camberwell Family Interview. Thirty two percent of patients
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living with relatives or friends had high face-to-face contact with a relative showing 
high EE; put another way, 87% of all Nithsdale schizophrenic patients were not living 
in a high contact/high EE family. Parents were more critical than spouses, and more 
showed emotional overinvolvement. A prospective 12 month follow-up identified 
relapsing patients. There was no difference in relapse rates in patients living on their 
own, with low EE or with high EE relatives. Amount of contact with high EE relatives 
did not affect relapse rates.
A further census in 1987 identified 77 patients living at home with relatives or friends. 
Sixty three relatives of 52 of these patients were offered a package of treatments by 
professionals working in an everyday NHS setting: educational seminars, relatives' 
groups and family meetings. Thirty two relatives refused intervention. Of the 31 
relatives who agreed, 14 attended neither the educational seminars nor the relatives' 
groups. Seventeen relatives had a mean of 10 treatment sessions but there was little 
change in their level of EE after intervention. The number of patients who relapsed was 
the same in the 18 months before and after intervention, although the total number of 
relapses fell after intervention.
By 1990 30 relatives and 30 schizophrenic patients had lived together continuously for 
five years. The relatives had had their level of EE assessed on three separate occasions 
over the five years, namely in 1985, 1987 and 1990. In the majority of relatives (63%) 
the level of EE was stable over time. Patients who relapsed were evenly spread 
throughout those living in a consistently high, consistently low or fluctuating EE home. 
However, patients living in low EE homes who did relapse did so significantly less 
often than those who relapsed and were living in high or fluctuating EE homes.
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MOTOR DISORDERS
The prevalence of abnormal movements, side effects of the antipsychotic drugs, was 
examined in the 1981 cohort. Thirty one percent of patients had parkinsonism and 31% 
tardive dyskinesia (TD). Patients with TD were significantly older than those without 
TD and more showed flattening of affect and social withdrawal. A repeat census in 
1989 identified 161 patients, 146 of whom were assessed for the presence of akathisia 
(18%), pseudoakathisia (5%), TD (29%) and parkinsonism (27%). Forty four percent 
had no movement disorder, 36% one and 20% more than one movement disorder. The 
presence of TD had also been assessed in 61 of the 146 patients in 1981 and 1984. Only 
8% showed TD on all three occasions. There was no relationship between plasma 
antipsychotic drug levels and akathisia, parkinsonism or TD. More non-righthanded 
than right-handed patients showed TD. Patients with parkinsonism or receiving an 
antiparkinsonian drug more often had a history of at least one definite obstetric 
complication.
OBSTETRIC COMPLICATIONS
Fifty one mothers of 54 patients of the 1989 cohort were interviewed to obtain obstetric 
histories of patients and their sibs. There was no statistically significant difference in 
the proportion of schizophrenic patientss (35%) and sibs (29%) who had at least one 
definite obstetric complication. There was also no evidence that patients with a history 
of obstetric complications were less likely to have a first degree relative with a history 
of psychiatric illness leading to inpatient care. There was a trend for TD to be more 
common in those patients with no obstetric complications, but a family history of 
schizophrenia.
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1 INTRODUCTION
INTRODUCTION
Over the past 30 years there have been two radical changes in the management of the 
schizophrenic patient. Firstly, although the mean length of a schizophrenic illness is 
approximately 15 years (Cooper, 1978), most patients now spend most of their time 
outside hospital - so called ’community care'. This is illustrated in Tables 1.1 and 1.2. 
The total number of residents in Scottish mental illness hospitals and psychiatric units 
has fallen between 1970 and 1990 from 18,297 to 13,229, a fall of 28%. The principal 
reason for this fall is the reduction in the number of schizophrenic inpatients, from 
5,109 to 2,742, a fall of 46%. In contrast, changes in the number of patients suffering 
from the second most common psychiatric diagnosis leading to admission in 1970, 
namely senile and presenile organic psychotic conditions, have been in the opposite 
direction. The number has increased over the 20 years from 3,006 to 4,724, an increase 
of 57%.
Part of the reduction in the number of residents with schizophrenia may be due to a 
falling incidence of the disease (Der et al, 1990). As it is probable that almost all 
patients with schizophrenia will have at least one inpatient admission, first admission 
rates will reflect incidence. Table 1.3 shows that first admissions between 1975 to 
1990 dropped from 495 to 399, a fall of 19%.
However, a more important reason for the reduction in the number of residents with 
schizophrenia, and the second radical change in the management of schizophrenia, was 
the introduction in the 1950’s of antipsychotic medication. Such drugs in placebo- 
controlled studies were found to be effective in the treatment of the acute episode (e.g. 
NIMH Psychopharmacology Service Centre Collaborative Study Group, 1964) and as 
maintenance therapy (Hogarty and Ullrich, 1977). Antipsychotic drugs have improved
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and maintained the patient's mental state so that life outside hospital has become 
possible. Antipsychotic drugs do not prevent relapse, they postpone it. Thus 
readmission(s) to hospital will prove necessary for most patients (Scottish 
Schizophrenia Research Group, 1992). This is illustrated in Table 1.3. Although 
patients are spending less total time in hospital the ratio of readmissions to first 
admission of schizophrenic patients has increased between 1975 and 1990 from 2,124: 
495 (4.3:1) to 3,215: 399(8.1:1).
In summary, a generation of schizophrenic patients has grown up since the introduction 
in the 1950's of antipsychotic medication and community care, and over the past two 
decades many have been exposed to long-term maintenance antipsychotic treatment. 
However, there have been very few studies describing the impact of these 
developments on a community of schizophrenic patients. The Nithsdale surveys over a 
ten year period have tried to do this.
Nithsdale (see map) is one of the four local authority districts of Dumfries and 
Galloway Region in South West Scotland and is historically ancient and geographically 
discrete. The author has had clinical responsibility for most schizophrenic patients in 
Nithsdale throughout the years of the Nithsdale project.
The studies fall into three broad groups. Firstly, patients have been examined to 
determine psychiatric and social handicaps, and to assess the social adjustment of those 
living outside hospital. Secondly, the family life of the patient is described: this 
includes an assessment of the prevalence of relatives' high 'expressed emotion', the 
effect of family life on schizophrenic relapse, the effectivenesss of family treatment, 
and the stability of attitudes of relatives towards patients over five years. Thirdly, the 
principal side effects of antipsychotic drugs, namely motor disorders, have been
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assessed: prevalence, persistence and relationship to plasma neuroleptic levels are 
described, and their relationship to obstetric complications.
Finally, in view of the current interest in schizophrenia as an organic illness (Roberts, 
1991), the Nithsdale project has examined the relationship between obstetric 
complications and schizophrenia.
The following 11 papers all have, or are about to be, published in the British Journal of 
Psychiatry.
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TABLE 1.1
MENTAL ILLNESS HOSPITALS AND PSYCHIATRIC UNITS. 
RESIDENTS, BY SEX
1970 1975 1980 1985 1990
Number of 
residents
TOTAL 18297 16841 15164 14094 13229
Male 8433 7521 6547 5745 5431
Female 9864 9320 8617 8349 7798
Rate per 
100,000 
population
TOTAL 351 323 294 274 259
Male 336 300 264 232 220
Female 364 345 322 314 296
Taken from Scottish Health Statistics 1991. Edinburgh: Information and Statistics 
Division, Common Services Agency for the Scottish Health Service.
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TABLE 1.2
MENTAL ILLNESS HOSPITALS AND PSYCHIATRIC UNITS. 
RESIDENTS BY SEX AND DIAGNOSIS
RESIDENTS MALE FEMALE
1975 1980 1985 1990 1975 1980 1985 1990
Senile and 673 803 1110 1218 2333 2686 3418 3506
presenile
organic
psychotic
conditions
Schizophrenic 3013 2470 2013 1655 2096 1692 1387 1087
psychoses
Taken from Scottish Health Statistics 1991. Edinburgh: 
Information and Statistics Division, Common Services 
Agency for the Scottish Health Service.
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TABLE 1.3
MENTAL ILLNESS HOSPITALS AND PSYCHIATRIC UNITS.
INPATIENT ADMISSIONS (ALL, FIRST AND READMISSIONS) BY SEX AND DIAGNOSIS
ADMISSIONS MALE FEMALE
1975 1980 1985 1990 1975 1980 1985 1990
Senile and presenile ALL 545 916 1480 1955 1271 1975 3271 3698
organic psychotic FIRST 404 567 743 844 888 1163 1512 1425
conditions READMISSIONS 141 346 721 1088 373 802 1734 2248
Schizophrenic ALL 1358 1589 1843 2189 1261 1417 1433 1446
psychoses FIRST 264 253 204 238 231 235 177 161
READMISSIONS 1094 1330 1637 1937 1030 1177 1252 1278
Taken from Scottish Health Statistics 1991. Edinburgh: Information and Statistics Division, 
Common Services Agency for the Scottish Health Service.
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THE PATIENT
2.1 PSYCHIATRIC AND SOCIAL HANDICAPS 
r  g  McCr e a d ie
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SUMMARY
A review of all known schizophrenic patients from a discrete geographical area, 
Nithsdale in Dumfries and Galloway Region, found a point prevalence of 2.38 per 1000 
of the total population; this figure fell to 1.73 when only Feighner positive 
schizophrenic patients were considered. Only three percent of the population 
interviewed had no abnormality in mental state or behaviour; negative schizophrenic 
symptoms were prominent, positive symptoms uncommon. Approximately one 
quarter were in-patients, who were an atypical group, showing much more obvious 
social and psychiatric disability. In- and day patient care and state benefits for 
schizophrenic patients cost each member of the Nithsdale community approximately 
£12 a year.
19
A generation of schizophrenic patients has grown up since the introduction in the 1950s 
of neuroleptics and community care, and in the past decade they have been exposed to 
long-term maintenance anti-psychotic drugs. However, there have been very few 
community studies describing the impact of these developments. A recent detailed 
description of schizophrenic in-patients (Owens and Johnstone, 1980) showed many 
such patients continuing to have multiple social and clinical handicaps, while a review 
of patients in the community (Cheadle et al, 1978) found such handicaps were 
moderately severe. No recent study in the United Kingdom, however, has identified all 
schizophrenic patients from a discrete geographical area and described their handicaps. 
The present study has attempted this.
METHOD
Area
Nithsdale, an historically ancient and geographically discrete part of Dumfries and 
Galloway Region, has an area of 550 square miles and a population of 56,000 (General 
Registrar Office, Scotland, 1981). It is largely rural, but contains the market town of 
Dumfries (population 31,000) and three other small towns along the banks of the River 
Nith. Psychiatric services are provided by Crichton Royal Hospital. It is probable that 
very few patients from Nithsdale receive treatment elsewhere, especially as the 
Crichton has had amenity beds for many years and the two nearest psychiatric hospitals 
are 35 and 60 miles from Dumfries.
Patient identification
Patients included in the survey were all the in-patients, day patients, and out-patients of 
Crichton Royal Hospital who, on 1 March 1981, had a firm case record diagnosis of
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schizophrenia and whose home address was in Nithsdale. All general practitioners (n = 
32) in Nithsdale were sent a list of schizophrenic patients in their practice currently in 
contact with the Crichton. They were asked if there were any other schizophrenic 
patients known to the practice and receiving treatment. The Feighner criteria for 
schizophrenia (Feighner et al, 1972) were then applied to each patient, using 
information obtained from the case record and the clinical assessment (see below).
The following demographic, social, financial and clinical information was recorded: 
age, sex, marital status, number of children, place of birth, domiciliary and employment 
status, value of all financial benefits (including free prescriptions, if any), length of 
illness (as estimated from first hospital admission), length of total in-patient stay and 
current medication.
Assessment
Over the four weeks following the census date the mental state of patients was assessed 
by the author using the Manchester Scale for chronic psychotics (Krawiecka et al, 
1977); a 10 percent sample was assessed independently by a second psychiatrist to 
estimate inter-rater agreement. In-patient and day patient behaviour was assessed by 
senior nurses using the Wing Ward Behaviour Scale (Wing, 1961); the behaviour at 
home of patients living with relatives was assessed by community nurses through 
interviews with the relatives, also using the Wing Scale, with minor modifications. 
Parkinsonism and tardive dyskinesia were assessed using the Targeting Abnormal 
Kinetic Effects scale (TAKE) and the Abnormal Involuntary Movements Scale (AIMS) 
(Wojcik et al, 1980; US Department of Health, Education and Welfare, 1976); results 
of these assessments are reported separately (McCreadie et al, 1982a) as is an 
assessment of handedness (McCreadie et al, 1982b), determined by a series of tests 
(Annett, 1970).
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Statistics
Differences between groups were tested by the chi-square test (two-tailed tests 
throughout).
RESULTS
This study identified 133 schizophrenic patients, of whom 38 were in-patients (28 
percent), 23 day patients (17 percent) and 42 out-patients (32 percent). All general 
practitioners replied to the questionnaire. This identified a further 30 patients (23 
percent) of whom all except one had had contact with Crichton Royal at some time in 
the past. The figures gave a point prevalence of 2.38 per 1000 of the total population. 
When the Feighner criteria were applied, there were 97 'definite' or 'probable' 
schizophrenics, a point prevalence of 1.73 per 1000.
Three general practitioners refused access to eight patients but supplied some 
demographic and social information. A further seven patients attending only their 
general practitioner refused to be assessed clinically.
Demographic and social findings
Fifty-two percent of probands were male, 48 percent female; their mean age was 48 
years, range 20 to 94 years. Half had been born in Nithsdale, a further 11 percent in 
other parts of Dumfries and Galloway Region, 23 percent elsewhere in Scotland. 
Seventy-eight percent were from the town of Dumfries, where 55 percent of the general 
population of Nithsdale lives. Fifty-nine percent were single, 22 percent married, 14 
percent divorced or separated and 5 percent widowed; this compares with 40 percent 
single, 51 percent married and 9 percent widowed, divorced or separated for the general
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population of Dumfriesshire aged over 16 years (General Registrar Office, Scotland, 
1971). Sixty-eight percent had no offspring.
The following information excludes in-patients. Twenty-five percent lived with their 
spouse, 30 percent with parents and 27 percent alone. Seventy-five percent (68 percent 
of males) were unemployed, compared with 12 percent (13 percent of males) of the 
general population in Dumfries and Galloway Region (personal communication, 
Employment Service Agency); 18 percent of this group attended the hospital's 
industrial or occupational therapy department.
Financial findings
Ninety-five percent of in-patients were receiving state benefits (mainly non­
contributory invalidity payments), the average weekly value of which was £7.50. 
Seventy percent of other patients were also receiving benefits (invalidity, 
unemployment or supplementary benefit or retirement pension), the average value of 
which was £31.80. Thirty-eight percent of non-in-patients received free prescriptions 
and a further 14 percent had a prescription 'season ticket'. The assessed cost of in­
patient care at Crichton Royal at the time of the survey was £182 per patient per week 
(Dumfries and Galloway Health Board, 1981). This is a slight overestimate as the 
figure of £182 includes the cost of running the day hospital and the salaries and very 
considerable travelling expenses of community nurses, two of whom work mainly in 
Nithsdale with chronic schizophrenic patients. It is likely that the cost of day care is not 
far short of the cost of in-patient care. When only the cost of in- and day patient care 
and state benefits are considered, then, with 56,000 people in Nithsdale, the cost of 
caring for schizophrenic patients is approximately £12 per year to each member of the 
Nithsdale community. Taxes and national insurance and pension contributions paid by 
the small number of schizophrenic patients in open employment will slightly offset this 
cost.
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Clinical findings
The mean length of illness was 18 years, the median 14 years (range two months to 60 
years), the mean total length of in-patient stay eight years and the median one year 
(range one week to 60 years). Twenty-four percent of patients were receiving no anti­
psychotic medicatiron; 30 percent were receiving oral, 31 percent intra-muscular and 
15 percent both oral and intra-muscular neuroleptics. Thirty-two percent were 
receiving anti-parkinsonian medication and 25 percent other psychotropic drugs, 
mainly benzodiazepines (15 percent) or anti-depressants (9 percent).
Mental state
The mental state of all in-patients, day patients and out-patients and of 50 percent of the 
general practice patients was assessed (n = 118, i.e., 89 percent of the total group). The 
nine items on the Manchester Scale assess four positive schizophrenic symptoms 
(incongruity of affect, delusions, hallucinations and incoherence of speech), two 
negative schizophrenic symptoms (flattening of affect, poverty of speech) and three 
non-schizophrenic symptoms (depression, anxiety and retardation), each on five-point 
scale (0 = absent to 4 = severe). Affect was separated in the present study into 
'incongruous' and 'flat'. Inter-rater agreement, complete or partial (a difference of one 
point), ranged from 91 to 100 percent on eight items; it was 73 percent on the ninth, 
incoherence of speech.
In 18 percent of patients there was no abnormality in the mental state. Table 2.1.1 lists 
the symptoms in order of prevalence. The negative symptoms were most prominent, 
the positive least. Almost half the patients showed flatness of affect while less than 15 
percent exhibited hallucinations, incoherence of speech or incongruity of affect.
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Behaviour
The behaviour of all in-patients and day patients, 74 percent of out-patients, and 13 
percent of general practice patients (n = 96, 72 percent of the total group) was assessed.
The Wing Behaviour Scale assesses behaviour in the previous week. In 21 percent of 
patients no abnormality was detected. Table 2.1.2 lists the symptoms in order of 
prevalence. Social withdrawal, lack of leisure interests and limited conversation were 
found in about half of the patients. Socially embarrassing behaviour such as 
threatening behaviour or overactivity was uncommon.
Only three percent of patients whose mental state and behaviour were both examined 
had no abnormality on either assessment.
Differences between groups
Various groups were compared on the basis of demographic, social and clinical 
findings. Unless specified, differences stated below were significant at least at the 1 
percent level.
Feighner positive versus negative schizophrenics
Feighner positive schizohrenic patients (’definite' or 'probable') were older (P < 0.05), 
more of them were single, fewer had children, and more were unemployed. They had 
been ill longer (P < 0.02) and had spent a longer total time as in-patients.
Male versus female
More males were single (P < 0.05), more lived with their parents and fewer were 
unemployed (P < 0.02).
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In-patients versus other groups
More in-patients had been born in Dumfries and Galloway Region (P < 0.05), they 
were older, more were single, fewer had children and more were unemployed. In­
patients had been ill longer (P < 0.02) and had a longer total in-patient stay. More were 
on both oral and intra-muscular neuroleptics (P < 0.02). Flattening of affect (P < 0.02), 
poverty of speech and retardation of movement (P < 0.02) were more common in in­
patients and ordinary conversation, social mixing, spontaneous interests and pride in 
personal appearance were less common.
Out-patients versus general practice patients
Out-patients had had a longer total in-patient stay than general practice patients and 
more of them exhibited flatness of affect and retardation (P < 0.05).
DISCUSSION
The point prevalence which we found, 2.38 per 1000 of the total population, lies 
between the 1.98 found in 1974 in Camberwell, and the 2.77 found in Salford (Wing 
and Fryers, 1976). The Camberwell and Salford prevalence figures were obtained from 
case registers and did not include patients attending only their general practitioners. 
When Feighner positive schizophrenic patients only are considered, the prevalence in 
Nithsdale falls to 1.73. The Nithsdale figure must be an underestimate, as inevitably 
some schizophrenic patients have nothing to do with their general practitioner but 
continue to have symptoms. However, there are likely to be fewer such patients in 
Nithsdale than in urban areas, as it is a heavily doctored district where practitioners are
26
very much part of the community in which they live. The results will also be effected 
by some schizophrenic patients having drifted away from Nithsdale to such cities as 
Glasgow and Edinburgh; indeed, there seems to have been a drift from rural Nithsdale 
to Dumfries.
The application of the Feighner criteria distinguish two groups of patients, who differ 
mainly in age and length of illness. However, there are no differences between the 
groups on the basis of the patients' mental state or behaviour. The Feighner criteria 
tend to identify chronic patients (Overall and Hollister, 1979) as a main requirement is 
that a patient must have had symptoms for at least six months without a return to the 
premorbid level of psychological adjustment.
Approximately one quarter of schizophrenic patients in our survey were in-patients; 
this contrasts with both Camberwell and Salford, where in 1974 about two-thirds were 
in-patients. No doubt the shift to community care over the past seven years would now 
produce different figures in both these urban areas.
Although almost three-quarters of the schizophrenic patients were living out of 
hospital, social and psychiatric disability was still considerable. When compared with 
the general population fewer had married, and among those who had more marriages 
had ended in separation or divorce. The vast majority were unemployed. Only three 
percent of schizophrenic patients examined had no abnormality in either mental state or 
behaviour. Psychiatric disability, however, was 'quiet'. Flattening of affect and social 
withdrawal were most prominent; florid positive symptoms and embarrassing 
behaviour were uncommon. The latter symptoms are effectively controlled by 
neuroleptics (Crow, 1980); the former are much more difficult to manage.
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The finding that most schizophrenic patients are likely to be out of hospital means that 
the burden of their care has been transferred to the community. In many instances the 
'community' is the patient's family, and the stresses produced by the schizophrenic 
patient living at home have already been well documented (Creer and Wing, 1974). To 
relieve the burden on the family and to give support to patients living on their own, day 
care is offered to all Nithsdale schizophrenic patients without employment, but 
distances and problems with transport in a rural area dictate that only those living in or 
around Dumfries can reasonably be expected to attend. A subgroup likely to need 
considerable support in the future are those currently living with ageing parents; 
indeed, males in this category form 15 percent of the total schizophrenic population.
The most striking differences found were between in-patients and other groups. The 
former were older, had been ill longer and in terms of both mental state and behaviour 
were more disabled. Studies which nowadays confine themselves to in-patients are 
likely, therefore, to be examining a small and atypical group of schizophrenic patients. 
The number of patients examined who were attending only their general practitioner 
was small and, perhaps, not typical of the group as some refused to be interviewed. 
However, those who were assessed were less disabled than out-patients, a finding 
reported in another study (Leff and Vaughn, 1972). In Nithsdale this probably reflects 
willingness among general practitioners to care for less seriously disabled 
schizophrenic patients.
Although the majority of schizophrenic patients in Nithsdale are no longer living in 
hospital, the financial cost is still considerable. Such costs are extremely hard to 
estimate (Cheadle and Morgan, 1974), but when only readily identifiable costs were 
taken into account, £12 per person per year was the approximate cost to the Nithsdale 
community of caring for schizophrenic patients. If these findings are typical
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throughout the United Kingdom (which admittedly is highly speculative) then the cost 
of caring for schizophrenic patients nationwide must be approximately £650-700 m per 
year.
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TABLE 2.1.1
MENTAL STATE: PREVALENCE OF SYMPTOMS
SYMPTOM PERCENTAGE OF PATIENTS
SHOWING SYMPTOM
Flatness of affect 45
Retardation 33
Poverty of speech 29
Anxiety 28
Delusions 26
Depression 23
Incoherence of speech 14
Hallucinations 10
Incongruity of affect 8
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TABLE 2.1.2
BEHAVIOUR: PREVALENCE OF ABNORMALITIES
BEHAVIOUR
Social withdrawal
Leisure interests
Conversation
Slowness of movement
Underactivity
Personal appearance
Laughing and talking to self
Posturing and mannerisms
Threatening or violent behaviour
Overactivity
Behaviour at meal times
Personal hygiene
PERCENTAGE OF PATIENTS 
SHOWING ABNORMALITY
61
50
48
33
30
24
12
9
8
7
3
2
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2.2 SOCIAL ADJUSTMENT BY SELF-REPORT
R G McCREADIE 
E T  BARRON
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SUMMARY
The Social Adjustment Scale Self-report (SAS-SR) was completed by chronic 
schizophrenic patients (N = 82) living in Nithsdale, in Dumfries and Galloway Region. 
Relatives also assessed patients' adjustment. The questionnaire response indicated that 
scrutiny of the form by a professional immediately after completion is necessary. 
Patients' and relatives' assessment of the patients' overall adjustment correlated very 
closely, thus suggesting a schizophrenic patient can satisfactorily describe his own 
adjustment. The patients were less well adjusted than a normal community population 
in all areas except the parental role. The SAS-SR highlights for each individual where 
many of his problems lie, and therefore may act as a guide to specific rehabilitative 
measures.
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A recent community survey has shown that at any given time, approximately three- 
quarters of all known schizophrenic patients are probably living outside hospital 
(McCreadie, 1982a). As many patients continue to have psychiatric and social 
handicaps, further rehabilitation is usually necessary after discharge from in-patient 
care. The efficacy of such rehabilitation needs to be evaluated and any assessment 
should include a measure of social adjustment. In a busy community psychiatric 
service a short, simple, inexpensive assessment is required. The present study reports 
the use by chronic schizophrenic patients of the Social Adjustment Scale Self-Report 
(SAS-SR) (Weissman and Bothwell, 1976). Previous studies suggest the scale can be 
used successfully with non-psychiatric patients and with different psychiatric 
populations (Weissman et al, 1978). There have been no reported studies, however, on 
the use of the scale by both a schizophrenic patient and a relative, although when a 
modification of the original scale (Weissman and Paykel, 1974) was used by trained 
interviewers, agreement between schizophrenic patients and 'significant others' about 
the patient's social adjustment was found to be satisfactory (Glazer et al, 1980).
The present study aims firstly to determine the acceptability to patients of the self- 
report, secondly to compare patients' and relatives' assessment of the patient, and 
thirdly to compare patients' social adjustment with that of a normal population.
METHOD
Patients
The patients were drawn from the 1982 cohort of schizophrenic patients in Nithsdale, 
an historically ancient and geographically discrete part of Dumfries and Galloway 
Region. The original census (1.3.81) of all known schizophrenic patients in the area, 
in-patients, day-patients, out-patients, and patients known only to their general
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practitioner has been fully described elsewhere (McCreadie, 1982a) and identified 133 
schizophrenic patients. A repeat census on 1.3.82 identified 136 patients; of the 
original cohort five had died, four had moved away from the district, and three no 
longer had a diagnosis of schizophrenia. Fifteen patients had been added to the cohort 
during the intervening year; six had developed the illness de novo, four had moved into 
the district and five had either experienced a fresh episode of schizophrenia or had their 
diagnosis changed to schizophrenia. Of the 136 patients 28 were day-patients, 42 out­
patients, and 30 were known only to their general practitioner (total N = 100). These 
non-inpatients were the subject of the present study.
Assessment
The SAS-SR, which takes 10-15 minutes to complete, is a 54 item questionnaire 
examining adjustment during the previous two weeks. It yields an overall adjustment 
score and a rating of six role areas: work as a worker, housewife or student; social and 
leisure activities; relationships with extended family; and marital roles as a spouse, 
parent and member of the family unit. A final question asks about economic 
circumstances. The scale also has four descriptive categories: performance at expected 
tasks; amount of friction with others; finer aspects of interpersonal relations; and 
inner feelings and satisfactions. Each question is rated on a five point scale, with a 
higher score indicating greater impairment.
The SAS-SR was administered during the four weeks following the census date. The 
form was explained to patients and relatives and on return checked for completion. 
Patients were requested to complete the questionnaire at the hospital (Crichton Royal, 
Dumfries); some asked to take it home and a stamped addressed envelope was 
provided. Where patients who answered the questionnaire stayed with a relative (N = 
50), he also was asked to complete a questionnaire describing the patient's adjustment.
35
The form was either given to the relative at the out-patient department if he 
accompanied the patient or delivered to his home by a community psychiatric nurse. 
Again, where necessary, a stamped addressed envelope was provided.
RESULTS
Questionnaire response
Of the 100 patients, 82 answered the questionnaire. It was read to four because of 
illiteracy. Of the 18 who did not answer, one day-patient was in a general hospital at 
the time of the survey, two out-patients took the questionnaire home and never returned 
it, one out-patient did not understand it because of language difficulties, and 14 general 
practice patients did not attend for interview. Demographic and social data on the 82 
patients are shown in Table 2.2.1. All had a firm case record diagnosis of 
schizophrenia and 73 percent fulfilled the Feighner criteria for 'definite' or 'probable' 
schizophrenia (Feighner et al, 1972).
Questionnaires were returned by 41 out of 50 relatives (15 spouses, 21 parents, one 
child, and four more distant relatives). With the nine relatives who did not answer, the 
questionnaire had been delivered to their home and a stamped addressed envelope 
provided.
In 82 percent of questionnaires returned by patients and 71 percent by relatives, more 
than 90 percent of relevant questions had been answered; these formed the basis of the 
results. In almost all cases where less than 90 percent of questions had been answered, 
the questionnaire had been completed at home and returned by post.
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Patients' and relatives' assessment
In 24 pairs, both patients and relatives answered more than 90 percent of relevant 
questions. Correlations between patients' and relatives' scores for overall adjustment, 
five role areas, and four descriptive areas were measured by the product moment 
correlation coefficient (Table 2.2.2). The sixth role area, as a parent, is excluded as 
only three of the 24 patients were parents. Correlations were positive and high in 
overall adjustment and role areas except relationships with the extended and immediate 
family. In descriptive categories, correlations were high in performance and 
interpersonal behaviour, but negligible in friction.
To determine whether relatives consistently under or over-estimated patients' 
adjustment when compared with the patients' own assessment, means of scores 
obtained by patients and relatives in the various areas were compared using Students t- 
test. No significant differences were found.
Patients' assessment
Patients' assessment of themselves (N = 67) was compared with the self-assessment of 
a normal community sample (Weissman et al, 1978) (Table 2.2.3). The patients were 
significantly more handicapped in overall adjustment and all role areas except the 
parental role. There are no normative data for descriptive categories. The overall 
social adjustment of Feighner positive patients Cdefinite' or 'probable' schizophrenia) 
was less than in Feighner negative patients (P < 0.02). The following factors were not 
associated with differences in overall adjustment: sex, age, length of illness or stay in 
hospital, and domiciliary status.
Replies to individual questions help to describe the patients' adjustment. Only 27 
percent worked in open employment and 24 percent were married. Thirty-nine percent
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either had no friends or had met none in the previous two weeks, 34 percent had not 
gone out socially in the past two weeks, and 33 percent of the unmarried said they were 
completely uninterested in going out with a member of the opposite sex. Fifty-two 
percent had spent no time in the previous two weeks on interests or hobbies except 
watching television. Although most depended on social security benefits, 79 percent 
said they had enough money for their needs.
DISCUSSION
The study suggests that SAS-SR can be used reasonably successfully with chronic 
schizophrenic patients. The nature of the questionnaire was readily understood by most 
patients and relatives and when returned, more than 80 percent of patients and 70 
percent of relatives satisfactorily answered at least 90 percent of questions. In the 
majority of cases, both with patients and relatives, where the form was not returned or 
inadequately completed, the patient or relative had said he would return it by post. It 
would therefore seem advisable for the questionnaire to be scrutinised by a professional 
immediately after completion. There has recently appeared a British version of the 
SAS-SR (Cooper et al, 1982). The language has been modified somewhat and the 
rating scale simplified. However, there are as yet no normative data for a community 
population.
The assessment of overall adjustment by a patient corresponded very closely with that 
by his relative. Within various sub-scales, however, there were some differences in 
how the patient and relative saw the patient functioning, especially within both the 
immediate and extended family. It was also clear, and perhaps to be expected, that 
relatives and patients assessed friction differently; patients sensed friction where the 
relatives did not and vice versa.
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The findings in the present study extend previous work (Glazer et al, 1980) which used 
a modification of the SAS in schizophrenic patients and showed that with trained 
interviewers, correlations between patients and relatives were high. The present study 
suggests that an accurate assessment of overall adjustment can probably be made by the 
patient himself. This is an advantage, as many schizophrenic patients in the community 
live alone and their adjustment can not readily be assessed by anyone else. It may be, of 
course, there was collusion between the patient and his relative. Such collusion would 
presumably lead to an over-estimate of the patient's social adjustment. In this context, 
it is noteworthy that when the patients were compared with a normal American 
community sample (as stated above, there are no normative United Kingdom data), the 
patients' adjustment was less satisfactory in all areas, with the exception of the parental 
role.
The only factor which differentiated patients was whether or not they fulfilled the 
Feighner criteria for schizophrenia; Feighner positive schizophrenic patients were less 
well adjusted. This is understandable, as an essential requirement to fulfil the Feighner 
criteria is that the patient must have had symptoms for at least six months without a 
return to the premorbid level of psychological adjustment.
The study of Nithsdale schizophrenic patients reported previously (McCreadie, 1982a) 
showed that although the vast majority of patients in the community continued to have 
many psychiatric and social handicaps, the disability was 'quiet'. Flattening of affect 
and social withdrawal were prominent; florid positive symptoms and embarrasing 
behaviour were uncommon. The more detailed assessment in this study of patients' 
social adjustment confirms their withdrawal. Many had no friends, did not go out 
socially, and were completely unintersted in members of the opposite sex. The 
majority spent no time on interests other than television. Few perceived any unmet
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financial needs, although social security benefits were the main source of income. In 
short, they lead a quiet life and probably the majority cause little disturbance to most 
people in the community.
SAS-SR results highlight for each individual where many of his problems lie. An 
individual's score could act as a guide to specific rehabilitative measures, described in 
detail elsewhere (McCreadie, 1982b). Reassessment using the same scale might 
determine what improvements, if any, had been brought about by these measures. 
Care, though, must be taken in interpretation of such data. For example, if an 
unemployed patient subsequently finds work but performs poorly in this area, the 
overall adjustment score might fall. However, knowledge of each individual patient 
would prevent the clinician from falling into the trap of believing such a patient had 
deteriorated.
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TABLE 2.2.1 
SOCIAL AND DEMOGRAPHIC DATA
N = 82
%
Sex
Male 49
Female 51
Marital status
Single 55
Married 23
Widowed 2
Divorced/separated 20
Hospitalisation status
Out-patient 48
Day-patient 33
General practice patient 19
Age
< 25 years 4
25-44 years 50
45-64 years 44
65 + years 2
Length of illness
< 2 years 4
2 < 10 years 34
10 < 20 years 38
20 + years 24
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TABLE 2.2.2
CORRELATIONS BETWEEN PATIENTS' AND RELATIVES’ ASSESSMENT
OF PATIENTS' ADJUSTMENT
Rating Number of Pairs V P
Overall adjustment 24 +0.89 <0.001
Role areas
Work 19 +0.77 <0.01
Social/leisure 24 +0.77 <0.001
Extended family 24 +0.44 <0.05
Marital 10 +0.79 <0.01
Family unit 23 +0.02 NS
Descriptive areas
Performance 24 +0.91 <0.001
Interpersonal behaviour 23 +0.79 <0.001
Friction 23 -0.01 NS
Feelings 24 +0.54 <0.01
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TABLE 2.2.3
COMPARISON BETWEEN ADJUSTMENT OF PATIENTS 
AND NORMAL COMMUNITY POPULATION +
Rating
Patients Normals
N Mean score (SD) N Mean Score (SD)
Overall adjustment 67 2.00 (0.46) 482 1.59 (0.33)
Role areas
Work *** 62 1.59 (0.66) 399 1.40 (0.46)
Social/leisure * 67 2.64(0.71) 482 1.83 (0.52)
Extended family* 16 1.62 (0.69) 475 1.34 (0.33)
Marital *** 12 2.10 (0.64) 361 1.75 (0.48)
Parental 24 1.54 (0.71) 276 1.40 (0.42)
Family unit ** 67 1.86 (0.71) 464 1.46 (0.58)
Difference between groups * P < 0.001
**P<0.01 
*** P < 0.05
+ Taken from Weissman et al, 1978
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THE FAMILY
3.1 RELATIVES' EXPRESSED EMOTION: PREVALENCE, PATTERNS 
AND CLINICAL ASSESSMENT
r  g  McCr e a d ie  
A D T ROBINSON
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SUMMARY
A review of all known schizophrenic patients (N = 142) in Nithsdale, Scotland, 
found 50% were living with relatives or friends. Of these, 32% had high contact 
with a relative showing high expresed emotion (EE); put another way, 87% of all 
Nithsdale schizophrenic patients were not living in a high contact/high EE family. 
Parents were more critical than spouses, and more showed emotional over­
involvement. A retrospective review showed a trend, not of statistical significance, 
towards a higher admission rate to in-patient care in patients from high EE homes. 
Of relatives believed by a consultant psychiatrist to be neither critical nor hostile, 
80% fell into the low EE category, but only 55% thought hostile or critical belonged 
to the high EE category; that is, the clinician had a wider view of high EE than the 
Camberwell Family Interview. Relatives' scores on a short patient-rejection scale 
were higher in high EE than in low EE relatives, but the wide scatter of scores 
suggested the scale could not be used to identify an individual relative with high 
EE.
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Reports over 25 years from the MRC Social Psychiatry Unit in London have 
suggested the prognosis of schizophrenic patients discharged from hospital may 
depend on their living arrangements. Patients living with relatives who show high 
expressed emotion (EE) are more likely to relapse, especially if face-to-face contact 
between patient and relative is high and the patient is unprotected by maintenance 
antipsychotic medication (Brown et al, 1962, 1972; Vaughn & Leff, 1976a). These 
findings have become of increasing clinical relevance in recent years as in both the 
UK and USA family therapy which includes education, relatives' groups and family 
sessions has been shown to reduce contact and lower EE, and thus substantially 
reduce relapse rates (Leff et al, 1982, 1985; Falloonetal, 1982, 1985).
Both the UK and USA studies examined patients in an urban setting. A study in 
Chandigarh, Northern India found different levels of expressed emotion (Leff, 
1986); whether this was due to rural or cultural factors is not certain. The present 
study is the first to examine schizophrenic patients living in a rural area in the West. 
It is also the first to assess the prevalence of high EE in a community; in contrast 
with previous studies it does not confine itself to patients recently admitted to in­
patient care. By assessing prevalence the amount of work likely to face a NHS 
clinician willing to embark on prophylactic family therapy can be estimated. The 
study also describes patterns of EE in different types of relative, and examines, 
retrospectively, rates of admission to in-patient care in patients living on their own, 
and with different categories of relative.
If clinicians are prepared to carry out family therapy they must be able to recognise 
high EE. EE is currently assessed by the Camberwell Family Interview (CFI), 
which cannot be used without specialised training and is time consuming; it is 
therefore not suitable for use in everyday clinical practice. Are there any shortcuts
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in the assessment of EE? The present study examines two possibilities, firstly an 
experienced clinician's hunch, and secondly a short 'patient rejection' scale 
administered to relatives by a community psychiatric nurse.
METHOD
Patients
Patients were drawn from Nithsdale, a rural, historically ancient and geographically 
discrete part of Dumfries and Galloway Region, Scotland. Those included were all 
in-patients, day-patients and out-patients of Crichton Royal Hospital, Dumfries, 
who on the census date (1 July 1985) had a firm case record diagnosis of 
schizophrenia and whose home address was in Nithsdale. Also, all general 
practitioners in the area replied to a questionnaire which identified other 
schiophrenic patients known to the practice and receiving treatment but not known 
to the hospital. The census identified 142 schizophrenic patients; as the population 
of Nithsdale is 56,000, this gives a point prevalence of 2.53 per 1000 of the total 
population. Sixty-eight percent fulfilled the Feighner criteria for 'definite' or 
'probable' schizophrenia (Feighner et al, 1972).
At the time of the census 20% were long-stay in-patients, 28% lived alone or in 
lodgings, and 2% lived with relatives under 18 years of age. Fifty percent (N = 72) 
were living with adult relatives or significant others and it was these on whom the 
present study focused. Forty nine percent of such patients were male (mean age 42 
years, s.d. 12 years, range 21-66 years; mean length of illness, as estimated from 
first psychiatric hospital contact, 14 years, s.d. 10 years, range 1-40 years) and 51% 
female (mean age 50 years, s.d. 13 years, range 27-79 years; mean length of illness 
18 years, s.d. 12 years, range 2-48 years).
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Scrutiny of case records identified all Nithsdale schizophrenic patients admitted to 
psychiatric in-patient care in the year preceding the census, 1 July 1984 - 30 June 
1985.
Relatives
The type of relative with whom the 72 patients were living is shown in Table 3.1.1.
2
More males than females were living with parents (x 6.75, P < 0.01). Relatives of 
12 patients were not interviewed; six patients had refused to take part in any of the 
previous Nithsdale surveys; a general practitioner refused access to a seventh 
patient; three patients refused access to relatives; and two relatives refused to be 
interviewed. Of the 12 patients, two had had no previous psychiatric admissions 
and the mean time from the census to the previous admission in the remaining ten 
was 12 years (s.d. 8 years, range 2-26 years).
Assessment
One of us (A.D.T.R.), trained in the use of the CFI by Dr Christine Vaughn, carried 
out all interviews which on all but three occasions took place in the patients' homes 
over a three month period following the census. Interviews were taped and an 
assessment made from the recordings of the five main components of EE, namely 
criticism, hostility, emotional over-involvement, warmth and positive comments. 
The amount of face-to-face contact between relative and patient during a typical 
week was also assessed through the construction of a time budget; more than 35 
hours per week indicates high contact (Vaughn & Leff, 1976a). The husband or 
wife of a married patient was always seen; where an unmarried patient lived with 
both parents, both mother and father were interviewed. In all, 70 relatives or 
friends were seen. A relative fell in the high EE category if he had a score of 6 or 
more critical comments, any degree of hostility, or a rating of 3 or more on 
emotional over-involvement (EOI) (Leff et al, 1982).
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At the same time as the CFI ratings were made the consultant psychiatrist 
(R.G.McC), responsible for the patients’ clinical management and blind to the 
ratings, made his own assessment of expressed emotion through the use of a simple 
4-point global scale:
I think this relative (i) is probably neither critical nor hostile (group 1 
relatives), (ii) is possibly neither critical nor hostile (group 2), (iii) is 
possibly critical and/or hostile (group 3), (iv) is probably critical and/or 
hostile (group 4).
To make the assessment as simple as possible, no attempt was made to rate EOI. 
Over the same period, community psychiatric nurses visited relatives in their homes 
and asked them to complete a patient rejection scale (PRS) (Kreisman et al, 1979*). 
This is a 24-item questionnaire containing such statements as "I am very
disappointed in my ", "I wish my  had never been bom". The relative is
invited to respond to each statement in one of seven ways ranging from "I feel this 
way 'always'" through 'sometimes' to 'never'. Each item is scored 1-7 and a grand 
total obtained (range 24-168); a lower score indicates less hostility.
The questionnaire has been expanded somewhat since the first version 
was published (full details on request to Dr D Kreisman, New York 
State Psychiatric Institute, New York, 10032).
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RESULTS
Prevalence and patterns of high EE
At the time of the survey 58% (n = 35) of the 60 patients were living with low EE 
relatives, 42% (n = 25) with at least one high EE relative, and 32% (n = 19) with at 
least one high EE relative with whom they were in face-to-face contact for more 
than 35 hours each week. Thirty relatives showed high EE. The breakdown by type 
of EE was as follows: criticism, as evidenced by a score of 6 or more critical 
comments, without EOI, as evidenced by a rating of less than 3, was shown by 10% 
of relatives (n = 7), criticism and EOI by 21% (n = 15) and EOI alone by 11% (n = 
8). Hostility, as evidenced by a score of 1 or more, shown by 8% (n = 6) was never 
found without criticism. Sixteen of 21 mothers (76%) interviewed showed high 
EE, three of six fathers (50%) (that is, 70% of parents showed high EE); one of 
nine wives (11%), four of 14 husbands (29%) (that is, 22% of spouses); four of 
nine other first degree relatives (44%); two of three more distant relatives (67%); 
none of eight friends showed high EE. Parents had significantly higher scores 
when compared with spouses in mean number of critical comments (5.67 (s.d. 4.79) 
vs 2.82 (2.29): t-test, t = 2.60, P < 0.02), and also more showed EOI (63% vs 13%: 
x = 10.89; P < 0.001). There were no statistically significant differences in the 
percentage showing hostility (11% parents (n = 3) vs 4% (n = 1)) but the numbers in 
each group were very small.
Patients living in high EE homes, in low EE homes or on their own did not differ in: 
sex distribution, length of illness, and number of previous admissions. Patients 
living on their own were older than those living in high EE homes (mean 51 years
vs 43 years; t-test: t = 2.65, P < 0.02). More patients in high than in low EE homes
2
lived with parents (68% vs 14%; x = 15.88; P < 0.001).
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Admissions to in-patient care
Scrutiny of case records showed that all Nithsdale schizophrenic patients admitted 
to in-patient care in the year preceding the census (n = 27, 24% of all non long-stay 
in-patients) did so as a result of an exacerbation of a chronic schizophrenic illness 
or a fresh episode. There was no difference between admissions and non­
admissions in: age, sex distribution, marital status and length of illness.
Admissions had had more previous admissions than non-admissions (mean 7.3 vs 
4.9; t-test: t = 2.12, P < 0.05).
Patients were then grouped on the basis of domiciliary status and whether they had 
received maintenance antipsychotic medication in the year preceding the census or 
at least until the time of hospital admission (Table 3.1.2). Admission rates for the 
three main groups (patients living on their own, in low EE homes and in high EE 
homes) ranged from 22% to 36%; the trend, not statistically significant, was 
towards a higher admission rate in patients from high EE homes. Admission rates 
for patients in high and low contact with high EE relatives were virtually the same. 
There were no significant differences between relatives of patients admitted and not 
admitted in mean number of hours face-to-face contact with patients and mean 
scores on criticism, hostility, emotional over-involvement, warmth and positive 
comments sub-scales. A trend in patients living on their own or in low EE homes 
was that admission rates were lower in patients on antipsychotic medication (Table 
3.1.2) in contrast the trend in high EE patients was that admission rates were higher 
in patients on medication. No trend, however, reached statistical significance.
Comparison of CFI with consultant's assessment and PRS 
The consultant psychiatrist rated 54 of the 70 relatives; he believed his knowledge 
of the remainder was so slight that an assessment could not be attempted. He 
assigned 17 relatives to group 1 ("probably neither critical nor hostile"), 12 to group
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2, 14 to group 3 and 11 to group 4 ("probably critical and/or hostile"). When groups 
1 and 2 were combined, it was found that 23 out of 29 relatives (80%) fell into the 
low EE category as assessed by the CFI; when groups 3 and 4 were combined, 11 
out of 25 (44%) fell into the high EE category. Concordance rates were only 
marginally or not improved when relatives in groups 1 and 4 were compared 
respectively with those in low and high EE categories, and when groups were 
compared with relatives categorised by the criticism and EOI sub-scales of EE. The 
number of relatives showing hostility on the CFI (n = 4) was too small to warrant 
examination of concordance rates but two fell into group 3 and two into group 4.
Fifty-eight relatives completed the PRS; the remainder were not known to the 
community psychiatric nurse. Mean scores on the hostility questionnaire for 
different categories of relative as determined by the CFI are shown in Table 3.1.3. 
Although there were statistically significant differences between mean scores in 
different EE categories, there was such a wide scatter of scores in high EE relatives 
(see standard deviations in Table 3.1.3) that it was not possible to determine a cut­
off point on the PRS above which most high EE but few low EE relatives would be 
found.
DISCUSSION
Relatives of 12 patients were not interviewed and some might belong to the high EE 
category. However, either patients had no history of admission to a psychiatric 
hospital or had not been admitted for many years. If there is a relationship between 
high EE, relapse and subsequent in-patient care it is likely few of these relatives fell 
into the high EE category.
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The study, the first prevalence survey of high EE, found that in a community of 
schizophrenic patients 50% were living with relatives or friends and of these, 32% 
lived in high contact with high EE relatives, the family structure believed by Leff 
and colleagues to be most conducive to schizophrenic relapse. However, put 
another way, 87% of all Nithsdale schizophrenic patients were not living in a high 
contact/high EE family. In terms of absolute numbers, therefore, it is unlikely that 
at any given time many Nithsdale schizophrenic patients have to face this sort of 
family life. If these results obtain in other parts of the country, and if NHS 
clinicians wish to embark on prophylactic family therapy with schizophrenic 
patients at risk, then the amount of work involved is not likely to be great. It is 
possible of course that within an individual the level of EE fluctuates over time and 
that a higher or lower prevalence of high EE might have been found on another 
date. However, with highly enmeshed families (high EE, high contact), EOI in one 
study barely changed in relatives where no therapeutic intervention took place, at 
least over a 9-month period (Leff et al, 1982). Criticism appears less stable; a 
considerable reduction occurred over 9 months in some relatives where patients 
markedly improved (Brown et al, 1972).
A common family structure in Nithsdale is the male schizophrenic patient living 
with elderly parents (McCreadie, 1982a); such a patient may be at high risk as the 
present survey found parents were more critical and over-involved than spouses. 
Why this should be so is not clear. It has previously been suggested that more 
emotion is expressed by those with low rates of contact with friends and relatives 
(Brown et al, 1972). Perhaps parents are more isolated than spouses, most of whom 
were bom and brought up in Nithsdale and possibly had other supportive contacts 
more readily available outside the nuclear family.
Comparison of the present findings with other studies is very difficult, firstly
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because the Nithsdale survey examines prevlence while the others examined 
relatives of patients recently admitted to in-patient care, and secondly because 
different cut-off points in the subscales of criticism and EOI were used at different 
times to determine the presence or absence of high EE. At the suggestion of Dr Leff 
(personal communication), the fairest comparison is to use a cut-off of 6 for 
criticism and 4 for EOI (although 3 has been used in this and later studies); and to 
consider only relatives of Nithsdale schizophrenic patients recently admitted to in­
patient care, that is, during the previous year. The recalculation of results suggests 
the prevalence of high EE in rural Nithsdale (50%) might be similar to that in urban 
London (57%) but much higher than in Chandigarh, (23%; cut-off of 3 for EOI) 
and lower than in California (67%).
The results of the retrospective review must be treated very cautiously because, as 
discussed above, EE may in some cases fluctuate over time and if relatives had been 
assessed at the time of the patients' admission more might have shown high EE than 
in the prevalence survey. Nonetheless the retrospective results are of some interest. 
Although in the year previous to the survey there was a trend towards increased 
admission rates among schizophrenic patients living in high EE families there were 
no statistically significant differences in admission rates between patients living on 
their own or with relatives, between patients living with high and low EE relatives 
and between patients having little or much contact with high EE relatives. This 
contrasts sharply with relapse rates over 9 months in the prospective studies 
reported by Vaughn & Leff (1976a). In these studies, 13% of patients discharged to 
low EE homes but 51% of patients discharged to high EE homes relapsed. Also, 
medication in the present study did not appear to exert a prophylactic effect in 
patients living with high EE relatives; in contrast, in the studies of Vaughn & Leff, 
92% of patients discharged on no medication to high contact/high EE homes 
relapsed. However, the numbers of patients in the different Nithsdale subgroups
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are perhaps too small to warrant serious statistical analysis (for example there were 
only four patients in the high contact/high EE/no medication group).
It may be that other more important determinants of relapse swamp the contribution 
of family life in a community of schizophrenic patients. Patients admitted over the 
preceding year had had more previous admissions than patients who were not 
admitted; this may simply reflect severity of illness. Also, life events which are not 
assessed by the CFI can affect relapse rates (Leff & Vaughn, 1980). Alternatively, 
might there be protective factors in a rural community such as Nithsdale which do 
not exist in an inner-city area such as Camberwell? Most schizophrenic patients in 
Nithsdale were born and brought up in the area and many still have some contact 
with acquaintances, friends and more distant relatives outside the nuclear family 
home. Also, there is a well developed community psychiatric nursing service, a 
considerable number of patients are regular attenders at the day hospital, and most 
attend out-patient clinics. Perhaps such contributions outside the home are more 
widespread and better developed than in an urban area; advice, encouragement and 
support from these people may help to protect against the hostility, criticism and 
over-involvement of close relatives.
Neither the clinician's hunch nor the PRS proved to be an adequate shortcut to the 
assessment of high EE. If the consultant believed a relative was neither hostile nor 
critical, then it was highly likely that the relative fell into the low EE category as 
determined by the CFI. However, he had less success in determining which 
relatives had high EE. He appeared to have a much wider concept of hostility and 
criticism than that determined by the CFI and thus assigned many low EE relatives 
to the high EE category. If on the basis of his clinical hunch he and his team were to 
embark on family therapy for schizophrenic patients living with high EE relatives a 
substantial number of low EE families would find themselves in treatment - perhaps 
no bad thing.
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The PRS completed by relatives certainly distinguished in a statistical sense 
between high and low EE categories. However, because of the wide scatter of 
scores on the questionnaire in the high EE category, there was no clear cut-off point 
above which the clinician could confidently assert most high EE but few low EE 
relatives would be found. The PRS, therefore, may be of use for research purposes 
but not appropriate in an everyday clinical setting where the purpose is to identify 
an individual relative with high EE. Statistical probability does not yield precise 
prediction.
As an important by-product of the study, valuable insights were gained into the 
families of the Nithsdale schizophrenic patients and we would like to conclude by 
recording some of our more vivid impressions. Interviewing the family and friends 
of a given patient was a dialogue about the lives of the people who have taken on a 
considerable burden of care with varying degrees of willingness. The impression 
left was of people struggling, but often succeeding in coming to terms with a major 
change in a child or spouse, a change that left that person unpredictable, sometimes 
dangerous. One father said that his world had shrunk to the small but chaotic world 
of his daughter. The most contented homes were often the group homes; it is 
surprising that in place of the expected emotional blunting there was warmth and 
positive regard. While many experiences were adverse, humour was not lacking, 
which was to be expected from a couthie people such as live in Nithsdale. Where a 
schizophrenic patient was married, the overall impression of the marriages was of 
stability with the offspring well cared for. Maybe the stigma helps to draw a family 
together to withstand any external threat. Any adverse effect of caring for 
schizophrenic children did not seem to be reflected in the mothers either. Two were 
aged over 90; both gave vivid interviews.
To see people in their homes gives an insight rarely gained in the out-patient
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department and a willingness by a doctor ('busy people') to take an interest in home 
life was remarked on favourably many times. Advice is needed for next-of-kin and 
must be greatly helped by knowing home circumstances (Kuipers & Bebbington, 
1985).
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TABLE 3.1.1
PATIENTS’ LIVING ARRANGEMENTS
Total Male Female
Patient lives with: % (n = 72) (n = 35) II
Parents 41 57 24
Spouse 42 34 49
Children) 4 0 8
Other relative 6 6 5
Friend 7 3 14
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TABLE 3.1.2
ADMISSION OF NITHSDALE SCHIZOPHRENIC PATIENTS TO IN-PATIENT
CARE IN PREVIOUS YEAR
TOTAL NUMBER PERCENTAGE
NUMBER OF OF
OF PATIENTS PATIENTS
PATIENTS ADMITTED ADMITTED
Lives alone 42 9 22
No medication 14 4 29
Receiving medication 27 5 28
Low EE family 35 9 26
No medication 14 6 43
Receiving medication 21 3 14
High EE family 25 9 36
No medication 6 1 17
Receiving medication 19 8 42
High EE/high contact family 19 7 37
No medication 4 1 25
Receiving medication 15 6 40
1. Medication unknown in one patient.
2. More than 35 hours per week in face-to-face contact.
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TABLE 3.1.3
SCORES ON PATIENT REJECTION SCALE
TYPE OF RELATIVE 
AS DETERMINED BY 
CAMBERWELL 
FAMILY INTERVIEW
NUMBER
OF
RELATIVES MEAN
SCORE(SD)
REJECTION SCORE
STUDENTS 
’t' P
High expressed 
emotion
25 68 (27) }
} 2.05
}
}
<0.05
Low expressed 
emotion
33 56 (18)
Hostile 5 93 (11) }
} 3.61 <0.001
Not hostile 53 58 (21) }
Critical 17 76 (25) }
} 3.40 <0.01
Not critical 41 55 (19) }
1 Any degree of hostility on CFI
2 Six or more critical comments on CFI
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3.2 DOES RELATIVES' HIGH EXPRESSED EMOTION PREDICT RELAPSE?
R G McCREADIE 
K PHILLIPS
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SUMMARY
A review of all known schizophrenic patients living in Nithsdale in South-West 
Scotland identified long-stay in-patients, patients living on their own and those living 
with relatives showing low or high expressed emotion (EE). A prospective 12-month 
follow-up identified relapsing patients, defined as those readmitted to hospital with 
exacerbation of schizophrenic symptoms or a fresh episode of illness, or, if not 
readmitted, with a significant increase in antipsychotic medication. There was no 
difference in relapse rates in patients living on their own, with low-EE, or with high-EE 
relatives. Amount of contact with high-EE relatives did not affect relapse rates. The 
different results obtained from the Nithsdale group compared with one from 
Camberwell are discussed.
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Reports over 25 years from the MRC Social Psychiatry Unit in London have suggested 
that schizophrenic patients living with relatives who show high expressed emotion 
(EE) are more likely to relapse, especially if face-to-face contact between patient and 
relative is high, and the patient is unprotected by antipsychotic medication (Brown et al, 
1962, 1972; Vaughn & Leff, 1976a). However, a retrospective review of all known 
schizophrenic patients living in Nithsdale found only a trend, not of statistical 
significance, towards a higher admission rate to in-patient care in patients from high- 
EE homes (McCreadie & Robinson, 1987). We report now a 12-month prospective 
study of relapse rates among Nithsdale schizophrenic patients living in long-stay in­
patient wards, and living in the community on their own, or with low-EE or high-EE 
relatives. We believe the study is unique, in that the rating of EE was made when 
patients were not in a state of relapse. If high EE is causally important in schizophrenic 
relapse, then the relapse rate over the months following assessment might be expected 
to be higher in the high than in the low-EE group.
METHOD
The identification of schizophrenic patients and the rating of EE in their relatives have 
been described in detail elsewhere (McCreadie & Robinson, 1987). Briefly, a census 
on 1 July 1985 of all known schizophrenic patients (n = 142) in Nithsdale, an 
historically ancient and geographically discrete part of Dumfries and Galloway Region 
in south-west Scotland, found 20% were long-stay in-patients; 30% lived alone, in 
digs, or only with relatives aged under 18 years; 50% were living with adult relatives 
or friends, and it was these on whom the present study focused. Forty-nine percent 
were males (mean age 42 years), of whom 57% lived with parents, and 51% female 
(mean age 50 years) of whom 49% lived with a spouse. A psychiatrist trained in the 
use of the Camberwell Family Interview (Vaughn & Leff, 1976b) rated EE in relatives 
and friends of 60 patients, and assessed the amount of face-to-face contact between
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patient and relative during a typical week. The husband or wife of a married patient 
was always seen; where an unmarried patient lived with both parents, both mother and 
father were interviewed. In all, 70 patients or friends were seen. A relative fell into the 
high-EE category if he made six or more critical comments, showed any degree of 
hostility, or had a rating of 3 or more on emotional over-involvement (EOI) (Leff et al, 
1982). The interviews took place over a 3-month period following the census. The 
results showed thta 58% of patients were living with low-EE relatives and 42% with at 
least one high-EE relative; parents were more critical and over-involved than spouses.
Relapse over 12 months after assessment, or following the census date in the case of in­
patients and patients living on their own was determined in two ways. Firstly, if a 
patient was readmitted to in-patient care, his or her case-records were scrutinised, and a 
decision made as to whether that admission was the result of an exacerbation of a 
chronic schizophrenic illness, or a fresh episode. Secondly, as not all patients who 
relapse are necessarily readmitted to in-patient care, medication prescribed to all 
schizophrenic patients over the 12 months was determined through examination of 
medication charts and out-patient records, and discussion with community psychiatric 
nurses and general practitioners. A relapse was deemed to have occurred where the 
dose of an antipsychotic drug was increased by at least 100%, where a patient on no 
antipsychotic medication was then prescribed such a drug, or where another 
antipsychotic drug was added to the pre-existing antipsychotic regime. Both 
assessments of relapse were made by psychiatrists blind to the EE ratings. Finally, as 
part of routine ward practice, the social problems of all schizophrenic patients admitted 
to in-patient care over the 12 months were assessed by the Nithsdale team social worker 
using the National Institute for Social Work Case Review System (Goldberg & 
Warburton, 1979).
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RESULTS
Table 3.2.1 shows relapse rates over 6 and 12 months as defined by readmission, 
increase in medication, and by readmission and/or increase in medication ('total relapse 
rate'). Results are given separately for long-stay in-patients and for patients living on 
their own, in low-EE homes, and in high-EE homes. Results are also given for patients 
living in high contact with high-EE relatives (more than 35 h per week face-to-face 
contact). The results for patients living with relatives excluded 12 whose relatives were 
not rated for level of EE and one who was in a state of relapse at the time of EE 
assessment.
The following results refer to 'total relapse rates'. The relapse rate in all Nithsdale 
schizophrenic patients (excluding the one patient in a state of relapse at EE assessment) 
over 6 months was 13 out of 141 (9%) and over 12 months, 23 of 141 (16%). The 
relapse rate in patients from different settings ranged, over 6 months, from 7% (patients 
living on their own) to 13% (patients living with high-EE relatives) and over 12 months 
from 14% (patients living on their own) to 21% (in-patients). When measured by chi- 
squared tests, there were no statistically significant between-group differences in 
relapse rates; for example, the relapse rate over 12 months in patients living in high 
contact with high-EE relatives was 17% and the corresponding figure for patients living 
with low-EE relatives was 20%. Two of 32 patients (6%) who received no medication 
relapsed over 6 months, and 3 (9%) over 12 months; the corresponding percentages for 
patients receiving medication were 10% and 14%. In patients living on their own, only 
one of 11 (9%) on no medication relapsed over 12 months while five of 31 on 
medication did so (16%). In patients in low-EE homes, two of seven on no medication 
(29%) relapsed over 12 months, while five of 28 (18%) on medication did so. In high- 
EE homes, none of four patients on no medication relapsed, while four out of 20 (20%) 
on medication did so over 12 months.
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The above results refer to the total Nithsdale schizophrenic population, all of which has 
a firm case-record diagnosis of schizophrenia. The data were reanalysed for only those 
fulfilling the Feighner criteria for 'definite' or 'probable' schizophrenia (Feighner et al, 
1972). Relapse rates in 'Feighner positive' patients with different living arrangements 
were essentially the same as for the total Nithsdale group. However, more Feighner
positive than Feighner negative patients lived with high-EE relatives (80% of patients
2
living with high-EE relatives were Feighner positive: x = 3.96; P < 0.05).
When patients (excluding long-stay in-patients) who relapsed over 12 months were 
compared on social and demographic data with those who did not relapse, there were 
no statistically significant between-group differences in age, sex distribution, marital 
status, and length of illness; however, those who relapsed had more previous 
admissions (mean 8.8 vs 4.9). When tested by the Mann-Whitney U-test, this 
difference was significant (P < 0.001). There were no statistically significant 
differences between relatives of patients who relapsed and did not relapse in mean 
number of hours of face-to-face contact with patients, and mean scores on criticism, 
hostility, emotional over-involvement, warmth, and positive comment sub-scales of the 
EE rating.
Thirteen patients were admitted to in-patient care over 12 months. When rated by the 
National Institute for Social Work Assessment Schedule (Goldberg & Warburton, 
1979), the mean number of social problems at the time of admission was found to be 
4.4. The problems ranged from severe physical illness of a relative to a relative's 
increasing and excessive drinking to a serious debt of £1000. Numbers in each group 
were small, but there were no statistically significant differences in the mean number of 
problems in patients living on their own (3.8), with low-EE relatives (5.4), or with 
high-EE relatives (3.8).
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DISCUSSION
The present, unique, 12-month prospective study of schizophrenic patients living in a 
discrete geographical area has shown that relapse rates, as defined by readmission to in­
patient care because of schizophrenic symptoms or a fresh episode of illness, or a 
significant increase in medication, were no greater in patients living with high-EE 
relatives than in those living with low-EE relatives or on their own. The findings 
therefore do not support the Camberwell findings (Vaughn & Leff, 1976a) that high EE 
is an important aetiological factor in schizophrenic relapse.
However, the differences between the Nithsdale and Camberwell results must be 
treated with caution, as the two studies methodologically approached the problem from 
very different angles. The first major difference was that the Nithsdale study was 
naturalistic, while Camberwell was a controlled trial. In Nithsdale, patients had a firm 
clinical diagnosis of schizophrenia, and the majority (68%) fulfilled the Feighner 
criteria for definite or probable schizophrenia; in Camberwell, the diagnosis was made 
using the Present State Examination (PSE; Wing et al, 1974). In Nithsdale, relapse 
was defined by readmission and/or increase in medication, in Camberwell by a 
recurrence of schizophrenic symptoms as detected by the PSE. A second major 
difference was the timing of patient recruitment and EE assessment. In Nithsdale, 
patients living in the community were recruited when they were not in a state of relapse, 
and relatives assessed over the following 3 months; in Camberwell, patients entered 
the study and relatives were assessed at the time of in-patient admission for relapse. 
The finding in Nithsdale that relapse rates were no greater in high- than in low-EE 
homes assumes that EE levels did not change over the months after assessment. Is this 
assumption valid? We know of no study that has examined serially relatives identified 
initially as low EE, whether or not this assessment was made at the time of relapse.
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Previous work on high EE has suggested that in highly enmeshed families (high EE, 
high contact) EOI rated at the time of relapse barely changed in relatives where no 
therapeutic intervention took place, at least over a 9-month period (Leff et al, 1982). 
The same study found a small non-significant reduction in the number of critical 
comments made by untreated relatives, a reduction entirely accounted for by two 
relatives. However, another study found criticism to be less stable; a considerable 
reduction occurred over 9 months in some relatives where patients markedly improved 
(Brown etal, 1972).
The most convincing evidence in a prospective and naturalistic study, such as the 
Nithsdale review, that EE is not causally related to schizophrenic relapse, would be that 
the relapse rate in patients living in consistently low-EE homes (low EE both at initial 
assessment and at time of relapse) is as great as in consistently high-EE homes. A 
switch from low EE to high EE at relapse could be interpreted as relapse raising the 
level of EE, or vice-versa. It is the case in the present study, however, that over the 3 
months after assessment (a period of time too short to allow much change in the level of 
EE?), only one of 24 patients living in a high-EE family relapsed. If high EE is of 
major causal importance, then it is probable that more than one patient would have 
relapsed in this period.
If the methodological drawbacks in the present study are more apparent that real, what 
possible reasons could explain the difference between the Nithsdale and Camberwell 
results? Firstly the Camberwell sample, patients identified on admission to hospital, is 
biased towards relapse and chronicity. The Nithsdale schizophrenic population is not 
biased in this way and consequently might contain a high proportion of individuals with 
a good prognosis, some of whom might rarely be seen by hospital psychiatrists. This 
interpretation is supported by the low relapse rate of 16% over 1 year. Other studies of 
chronic schizophrenic patients in the community maintained on antipsychotic
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medication found relapse rates of 20% over 9 months, 26-29% over 15 months (Hirsch 
et al, 1973), and 17-20% over 6 months (Johnson, 1979). The effect of high EE may 
not be demonstrable in such a geographically based sample of individuals with an 
overall good prognosis in the same way that drug effects are hard to show in a good- 
prognostic group (Leff, 1973). The low relapse rate in Nithsdale complements the very 
long-term outcome studies of Bleuler (1983) and Ciompi (1980) which also revealed a 
much better prognosis for schizophrenic patients than is conventionally accepted.
A second explanation of the difference between Nithsdale and Camberwell might be 
that the association in Camberwell between high EE (rated at the time of relapse) and 
relapse was due to the relapsing patient who raised the level of EE in the relative. Leff 
et al, 1982, 1985) have argued that this is not so; they have shown that lowering EE in 
relatives through a package of social interventions including family sessions, a group 
for relatives, and an educational programme, was associated with a lower relapse rate in 
schizophrenic patients living in high contact with high-EE relatives. Thus high EE 
appears to be causally important. However, it is possible that such social interventions 
may have lowered also the relapse rate in schizophrenic patients living with low-EE 
relatives (not examined by Leff et al), and that lowering EE is merely a by-product of 
treatment which produces its effect in other ways. It is noteworthy that a recent 
American study (Hogarty et al, 1986), which found that no patient relapsed where EE 
changed from high to low, also found that a treatment package which included both 
social-skills training and family treatment could lower relapse rates in patients living 
with high-EE relatives without lowering the level of EE itself. That study also found 
that the amount of face-to-face contact between patient and relative did not affect 
relapse rates, as did the Nithsdale study.
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A third explanation of the Nithsdale results might be that factors more important than 
high EE precipitate relapse in schizophrenic patients, and thus swamp the effect of high 
EE. For example, patients who relapsed had significantly more previous admissions; 
this may simply reflect severity of illness. Also, life events are important in 
schizophrenic relapse (Brown & Birley, 1968), and in the present study, assessment by 
a social worker of stresses schizophrenic patients were experiencing at the time of 
admission to in-patient care found most patients had many pressing problems. Physical 
illness in a relative, developing alcoholism, and severe financial problems may be more 
important causes of stress than a critical relative. Such stresses were found as 
commonly in patients living on their own as with those living with relatives.
A fourth explanation might be that in a rural community such as Nithsdale, factors not 
found in an inner-city area such as Camberwell protect against high-EE relatives. Such 
possible factors have been discussed elsewhere (McCreadie & Robinson, 1987) but are 
worth summarising. Most Nithsdale schizophrenic patients have been born and 
brought up in Nithsdale, and many still have contact with more distant relatives and 
friends outside the nuclear home. Most patients are supervised at home by community 
psychiatric nurses who themselves have worked for many years in the area, most attend 
an out-patient clinic, and a significant minority attend a day hospital. Some patients 
also have contact with other consistent agencies such as social workers and voluntary 
organisations. Such relatives, friends and professionals might well provide sufficient 
long-standing and consistent warmth, support, and encouragement to protect against 
criticism and hostility within the home. It is possible that such long-term support is not 
found in an inner-city area such as Camberwell with its more rapid turnover of both 
patients and professionals. The low overall relapse rate in Nithsdale, 16% over 12 
months, may be due to a high proportion of good-prognosis patients (see above), and 
possibly these protective factors contribute to the good prognosis.
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Previous work has suggested that maintenance antipsychotic medication is especially 
useful in protecting patients living with high-EE relatives (Vaughn & Leff, 1976a). 
Although numbers were small, no such effect was found in the present study; indeed, 
in high-EE homes, none of the patients on no medication relapsed. The Nithsdale 
findings are not surprising, as the study was in no sense controlled, but simply an 
examination of clinical practice. It is the policy in Nithsdale to give as little 
antipsychotic medication to schizophrenic patients as possible, and efforts have been 
made over the years to reduce cautiously and discontinue medication. Also, the 
'protective factors' discussed above may protect non-medicated patients against relapse.
More Feighner positive than negative patients lived with high-EE relatives. The main 
criterion which determines if a schizophrenic patient is Feighner positive is length of 
illness - the patient must have experienced at least 6 months of symptoms without a 
return to the previous level of functioning. Thus, the more chronically ill patients are to 
be found in high-EE homes. It is possible that high-EE relatives have a more damaging 
long-term effect on patients, but on the face of it, it is more probable that patients with 
longstanding deficits produce more hostility and criticism in relatives.
Our tentative conclusion in this naturalistic study is that there is no clear association 
between high EE measured when patients are in remission and relapse rates of 
schizophrenic patients over a 12-month period. Methodological drawbacks in the 
present study cannot be ignored, but the results suggest that there is not necessarily a 
causal relationship between high EE and relapse. More studies of the present 
naturalistic kind, which rate EE serially, are urgently needed.
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TABLE 3.2.1 
RELAPSES OVER 6 AND 12 MONTHS
Living
arrangement
Relapses over 6 months Relapses over 12 months
Relapses
by
admission
Relapses
by
increase in 
medication
Relapses
by
admission 
and/or 
increase in 
medication
Relapses
by
admission
Relapses
by
increase in 
medication
Relapses
by
admission 
and/or 
increase in 
medication
N % N % N % N % N % N %
Lives alone 
(n=42)
3 7 3 7 3 7 4 10 6 14 6 14
Lives with low- 
EE relative 
(n=35)
2 6 4 11 4 11 5 17 6 18 7 20
Lives with high- 
EE relative 
(n=24)
2 8 1 4 3 13 4 17 2 8 4 17
Lives in high 
contact with 
high-EE 
relative (n=18)
2 11 0 0 2 11 3 17 1 6 3 17
Long-stay
in-patients
(n=28)
" 3 11 " 6 21 ■
Total - - 13 9 - - 23 16
The table excludes one patient in relapse at time of EE assessment.
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3.3 DO RELATIVES WANT FAMILY INTERVENTION - 
AND DOES IT HELP?
R G McCREADIE 
K PHILLIPS 
J A HARVEY 
G WALDRON 
M STEWART 
D BAIRD
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SUMMARY
Sixty three relatives of 52 schizophrenic patients living at home in Nithsdale in South 
West Scotland were offered a package of treatments by professionals working in an 
everyday NHS setting: educational seminars, relatives groups, and family meetings. 
Thirty-two relatives refused intervention; the commonest reason was "things are fine at 
the moment". Of the 31 relatives who agreed, 14 attended neither the educational 
seminars nor the relatives' groups, both of which were held in the local psychiatric 
hospital. These findings demonstrate the difficulty in engaging relatives in treatment. 
Seventeen relatives had a mean of 10 treatment sessions and formed the intervention 
group. There was little change in relatives' level of expressed emotion after 
intervention. The number of patients who relapsed was the same in the 18 months 
before and after intervention, but the total number of relapses fell after intervention.
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A recent consistent finding in schizophrenia research is the impact family intervention 
has on relapse rates. Different forms of intervention in the United Kingdom (Leff et al 
1982, 1985, 1989; Tarrier et al 1988, 1989), and in the United States (Falloon et al 
1982, 1985; Hogarty et al 1986) have produced a reduction in relapse rates which may 
be associated with a reduction in the level of relatives' expressed emotion (EE).
The reported studies have involved research teams in addition to clinicians responsible 
for patient care. "The application of the results in a routine way to the work of the busy 
clinical team must be the next phase" (Kuipers and Bebbington, 1988). The present 
study attempts to answer the following questions: in an everyday NHS setting, do 
relatives want intervention; does such intervention lower relatives' EE; and is there a 
reduction in relapse rates?
METHOD
The identification of schizophrenic patients has been described elsewhere (McCreadie, 
1982a; McCreadie and Robinson, 1987). Briefly, repeat censuses since 1981 in 
Nithsdale, an historically ancient and geographically discrete part of Dumfries and 
Galloway Region in South West Scotland, have identified all known schizophrenic 
patients - inpatients, daypatients, outpatients and patients known only to their family 
doctor. A repeat census on 1.1.87 identified 77 patients living at home with relatives or 
friends: it was these on whom the present study focused. The patient was informed of 
the purpose of the study by the consultant responsible for his care (RGMcC) and if 
consent was given an approach was made by the consultant to the relatives with whom 
the patient was living. Frequently both these interviews were lengthy. If relatives then 
consented a psychiatrist (KP) trained in the use of the Camberwell Family Interview 
rated EE in relatives and assessed the amount of face to face contact between patient 
and relative during a typical week. A relative fell into the high EE category if he made
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six or more critical comments, showed any degree of hostility or had a rating of three or 
more on emotional overinvolvement (Leff et al 1982); more than 35 hours a week 
indicated high contact (Vaughn and Leff, 1976).
Relatives were offered a package of treatments: educational seminars, relatives
discussion groups, and family meetings. The seminars, held weekly at the hospital, 
lasted approximately one hour, and were led by a psychiatrist of four years' experience 
(GW). They covered the main areas of aetiology, symptoms, treatment and prognosis. 
Relatives were encouraged to ask questions. The relatives groups, also held weekly at 
the hospital and lasting one to one and a half hours, were led by two social workers who 
had been qualified for seven and six years, and were both Mental Health Officers (JH 
and DB). One had attended a one year course on family therapy on a day release basis 
at the Scottish Institute of Human Relations, Edinburgh. The groups focused on the 
day-to-day problems of coping with a schizophrenic relative. One principal aim was to 
bring high and low EE relatives together, and encourage low EE relatives to offer their 
solutions. Family meetings which included the patient were held weekly or fortnightly, 
and were led by a social worker in the patient's home (JH or DB). They focused on 
everyday problems of living.
Relatives' EE and amount of contact with the patient were reassessed at the end of 
treatment. The interviewer was not told if the relative had in fact taken part in the 
intervention programme (see below), nor did he ask the relative; inevitably, however, 
the topic cropped up on occasion during interviews.
Patients were followed for 18 months after intervention. The number of relapses for 
that 18 month period, and an equivalent 18 months before intervention was determined. 
As in a previous study (McCreadie and Phillips, 1988), relapse was defined in two 
ways. Firstly, if a patient had been readmitted to inpatient care his or her case records
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were scrutinised, and a decision made as to whether that admission was the result of an 
exacerbation of a chronic schizophrenic illness or a fresh episode. Secondly, as not all 
patients who relapse are necessarily readmitted to inpatient care, medication prescribed 
to the patients over the 18 months was determined through examination of medication 
charts and outpatient records. A relapse was deemed to have occurred where the dose 
of an antipsychotic drug was increased by at least 100 %, where a patient on no 
antipsychotic medication was then prescribed such a drug, or where another 
antipsychotic drug was added to the pre-existing antipsychotic regime. Assessment of 
relapse was made by a psychiatrist (MS) blind both to the EE ratings and whether or not 
the patients' relatives had had the intervention programme.
RESULTS
All 77 patients had a firm clinical diagnosis of schizophrenia, and 62% fulfilled the 
Feighner criteria for "definite" or "probable" schizophrenia (Feighner et al 1972). 
There were 35 males (mean age 43 years (range 21 - 68), mean length of illness 13 
years (< 1 year - 42 years) and mean time since last hospital admission 5 years (< 1 - 
21); and 42 females (mean age 44 years (18 - 78), mean length of illness 15 years (< 1 - 
50) and mean time since last hospital admission 6 years (< 1 - 30)). Relatives and/or 
friends of 25 patients were not interviewed: 10 patients lived with other schizophrenic 
patients and/or in a group home, six patients had made no contact in any of the previous 
Nithsdale surveys, three patients did not attend interview when consent was sought to 
approach relatives, one patient refused an approach to relatives, two relatives failed to 
keep appointments, a family doctor refused an approach to either a patient or her 
relatives, and two patients were not seen for administrative reasons. Thus 63 relatives 
of 52 patients were interviewed. Thirty one relatives agreed to intervention, 32 did not. 
There were no differences between those who did and did not agree in sex distribution, 
relationship to patient and numbers with low EE (Table 3.3.1); and in the following
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patient characteristics: sex, age and length of illness. In the refusal group, relatives 
with high EE and those who declined an assessment of their EE status equalled the 
number with high EE in the group agreeing to intervention. Eight out of 12 patients 
whose relatives agreed to and took part in the intervention programme (see below) had
been admitted to hospital during the previous year compared with 4 of 27 patients
2
whose relatives refused intervention (x = 8.19, P < 0.01). The principal reasons for 
refusing intervention were: "things are fine at the moment" (N = 12); "it's (the patient) 
who needs help, not me" (N = 6); "(the patient) doesn't want anyone else to know he 
has been ill" (N = 5). Other reasons given by a single relative included "I'm too busy", 
"I've coped all these years", "it's too late now".
Although 14 of 31 relatives agreed to intervention they failed to appear at the 
educational seminars and relatives groups; they only had one or two family meetings in 
their homes. The remaining 17 relatives were designated the intervention group. They 
had a mean of 10 treatment sessions (range 3 - 20: viz. educational seminars: mean 2 
(range 0 - 4); relatives groups: mean 3 (0 - 8); family meetings: mean 5 (0 - 14)). At 
least one member of each family had a minimum of 8 sessions (mean 12, range 8 - 20).
Sixteen of the 17 relatives had their level of EE and amount of contact with the patient 
measured before intervention. Five had high EE/high contact, 4 high EE/low contact, 2 
low EE/high contact and 5 low EE/low contact. Thirteen relatives were reassessed at 
the end of intervention. One high EE relative was now low EE, and one low EE high 
EE; the remaining 11 (6 high EE, 5 low EE) were unchanged. Two relatives in high 
contact were now low, two in low contact high.
Nine of the 12 patients whose relatives had intervention relapsed at least once in the 18 
months before intervention; six relapsed in the 18 months after intervention. Between 
them the 12 patients had 17 relapses over the 18 months before intervention and 8
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relapses in the 18 months after intervention. Readmission to hospital defined 23 of the 
relapses, a 100% increase in medication defined two. The number of relapses in the 7 
patients from high EE homes fell from 13 to 4 (sign test, P < 0.06).
General Comments
The relatives who took part in the intervention programme were in the main pleased 
with the results. They were initially nervous about attending the group, and needed 
encouragement from the group leader. They appreciated the educational seminars most 
and believed at the end they knew more about the illness, treatments available and 
prognosis. They were pleased that 'for a change' interest was being shown in relatives. 
They thought the relatives' groups were most useful if there was a crisis at home. They 
were relieved their experiences were not unique. Topics frequently discussed included 
violence, loneliness, childlike behaviour, withdrawal, refusal to take medication, and 
anxiety over suicide attempts. Both in the relatives groups and in the family meetings 
means of overcoming these problems were examined. Practical help through for 
example holidays and financial advice was appreciated.
During the 18 month follow up period most relatives believed that 'things were easier at 
home'. Also, a loose network amongst relatives continued after formal intervention 
stopped. The network was strengthened when many relatives and patients joined either 
the local recently established Mental Health Association or National Schizophrenia 
Fellowship. Thus eduation and support, organised by and for patients and relatives 
themselves continued. Relatives who refused intervention did not join either 
organisation.
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DISCUSSION
The present study is "different" (Bebbington, 1988) in that it examined 
schizophrenic patients in remission living in the community. Other studies of EE and 
family intervention have examined patients admitted to hospital after a relapse. Great 
caution must therefore be taken when results in this study are compared with others.
Perhaps the most important finding was the difficulty experienced in engaging 
relatives in treatment. Most relatives did not want to participate in the family 
intervention programme. Many reasons were given, but the statement "things are fine 
at the moment" occurred repeatedly. It was our subjective impression that in many 
cases this statement was accompanied by a mixture of resignation, pride and 
resentment. It is not surprising therefore that most relatives who did eventually agree to 
intervention were living with a patient who had been readmitted to hospital the 
previous year. A number of relatives said they would join an intervention programme, 
but did not then attend the educational seminars or relatives groups. Both these 
activities took place during the day at the hospital and this might have mitigated against 
attendance. In another recent study (Leff et al, 1989) 5 of 11 families failed to attend a 
relatives group carried out in central London. Leff and colleagues now believe it is 
particularly important to offer home visits to families who are unable or refuse to 
attend the relatives groups. It is clear therefore that vigorous outreach is necessary in 
order to enable relatives to accept an offer of help, particularly if they feel other offers 
have been unhelpful.
Although relatives who did participate in the intervention programme had a 
considerable number of sessions in one of the three treatment areas, there was virtually 
no change in their level of EE after intervention. There are three possible reasons for 
this. Firstly, the intervention may have been inadequate or did not continue long 
enough. Treatment was given by professionals who were experienced practitioners,
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but who did not have special skills in family intervention in schizophrenia. They were 
aware of the principles behind the intervention of Leff and colleagues, but had received 
no specific training from his group. The intervention in the present study is therefore 
an approximation of what was achieved in other studies; however, this probably 
reflects clinical reality as it is unlikely in the forseeable future that many professionals 
working in hard pressed NHS psychiatric facilities will be seconded for specialised 
training. A second possibility is that after family intervention the level of EE falls only 
gradually, and that if a reassessment of EE had been carried out at the end of the 18 
month follow-up period results might have been different. However, a previous study 
(Tarrier et al, 1988) found EE status had changed by four and a half months after 
intervention. Thirdly, it may be that the level of EE is robust, and is a stable dimension. 
Even in intensive intervention settings (Leff et al, 1982, 1985, 1989) 6 of 12 and 10 of 
16 relatives did not move from high to low EE. As the years pass in Nithsdale a 
considerable number of relatives have had their level of EE rated on a number of 
occasions, separated by many months. This will be the subject of a separate enquiry, 
but there is tentative evidence that the level of EE changes little over the years. In this 
context it is again necessary to emphasise that relatives were assessed when patients 
were not in a state of relapse.
Relapse was used as the outcome measure of intervention firstly because it allows easy 
comparison with most other previous studies, and secondly because it is readily 
understandable to clinicians. It might have been possible to use broader outcome 
measures such as family burden, problem solving, and role performance of patients. 
However, these more sophisticated measurements are not routinely applied in an 
everyday NHS situation. Although intervention did not alter greatly the number of 
patients who had at least one relapse, there was a fall in the total number of relapses 
over the subsequent 18 months, a fall which just failed to reach statistical significance 
at the 5% level in patients living in high EE homes (the sample size was small).
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Consideration of the total number of relapses is probably realistic and of importance to 
relatives. Other studies have shown that relapse rates can fall without a corresponding 
fall in high EE. In an American study (Hogarty et al,1986) this happened when social 
therapy and family intervention were combined; in a United Kingdom study (Leff et al, 
1989) it happened when face-to-face contact was reduced. If the finding in the present 
study is genuine, that there has been a fall in the total number of relapses, what factors 
in Nithsdale might be important? It is possible that an improved ability amongst 
families to solve problems has reduced both the patient's vulnerability and his 
environmental stress. In addition the much greater interest in relatives shown by 
doctors and social workers already well known to schizophrenic patients might have 
increased the family's sense of worth and support. Finally the continuing network 
amongst relatives during the follow-up period provided continuing mutual support. It 
is noteworthy that although relatives believed the educational seminars to be most 
helpful, a previous study (Tarrier et al, 1988) found education alone had no effect on 
relapse rates.
In conclusion, if professionals working in everyday NHS facilities wish to embark on 
family intervention they should probably offer such help to relatives living with 
patients who have recently been readmitted to hospital.
83
TABLE 3.3.1 CHARACTERISTICS OF RELATIVES
Sex
Male
Female
Relationship to 
Patient
Father
Mother
Husband
Wife
Child
Other
Level of Expressed 
Emotion
High
Low
Refused
Not known
Relatives who agreed 
to intervention 
% (N = 31)
48
52
23
32
13
10
16
6
48
48
4
Relatives who did 
not agree to intervention 
% (N = 32)
41
59
12
41
25
16
3
3
28
47
22
3
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3.4 RELATIVES' EXPRESSED EMOTION: STABILITY OVER FIVE YEARS 
AND ITS RELATION TO RELAPSE
r  g  McCr e a d ie  
L J  ROBERTSON 
D J HALL 
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SUMMARY
The level of expressed emotion (EE) in 30 relatives of 30 schizophrenic patients was 
assessed on three separate occasions over five years. EE was high on all three 
occasions in 25% of relatives, low on all three in 38% and fluctuating in 38%; that is, 
in the majority of relatives (63%) the level of EE was stable over time. Three relatives 
who had previously shown high EE had evidence of dementia at the time of the third 
assessment, and showed low EE. Forty-seven percent of patients relapsed at least 
once over five years; patients who relapsed were evenly spread throughout those 
living in a consistently high, consistently low or fluctuating EE home. However, 
patients living in low EE homes who did relapse did so significantly less often than 
those who relapsed and were living in high or fluctuating EE homes. A number of 
patients in consistently high EE homes did not relapse at all over five years. 
Assessment of EE at the time of relapse did not show consistently high EE ratings.
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The relationship between relatives' expressed emotion (EE) and schizophrenic relapse 
has been examined over a thirty year period (e.g. Brown et al, 1962, 1972, Vaughn 
and Leff, 1976a, Leff et al, 1982, Hogarty et al, 1986, Tarrier et al, 1988, 1989, Leff et 
al, 1990). In all such studies, the level of EE has been assessed at the time of relapse. 
However, it is not clear whether in the absence of family therapy the level of EE 
shown at the time of relapse persists over a long time. That is, is the level of EE 
constant, reflecting the relatives' fixed set of attitudes or is it a temporary state waxing 
and waning in association with the patient's mental state?
There has been some work on the stability of EE over a short period. For example, 
Brown and colleagues (1972) found that the proportion of relatives who expressed 
criticism fell from 30% to 14%, over nine months, but that emotional 
overinvolvement (EOI) showed 'less of a tendency' to fall. Leff and colleagues (1982) 
found that two of eight relatives changed spontaneously over nine months from high 
to low EE, as measured by criticism, but there was no change in EOI. Hogarty and 
colleagues (1986) found that 11 of 44 households moved from high to low EE over 
one year without family treatment. Tarrier and colleagues (1988) found that seven of 
16 relatives changed from high to low EE over nine months. Finally, Leff and 
colleagues (1990) in a study in Chandigarh in India found that 79% dropped from high 
to low EE over one year. All this work has examined changes in high EE. With 
regard to low EE, Tarrier and colleagues (1988) found one of 18 relatives moved 
from low to high EE over nine months. We know of no study which has examined the 
stability of EE over longer periods, nor of any studies, apart from our own (McCreadie 
and Robinson, 1987, McCreadie and Phillips, 1988, McCreadie et al, 1991), which 
have examined the level of EE before relapse.
It may well be that relatives show a variety of attitudes. Some may show persistently 
high and some persistently low EE over many years, and others a fluctuating level of 
EE. It has been suggested (Kuipers and Bebbington, 1988) that very low EE relatives
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cope well whatever the circumstances and very high EE relatives have multiple 
problems, and cope badly with most of them, including the patients. The third 
'vacillating' group may change category depending on their ability to learn new coping 
skills, spontaneously or through the intervention of others, and in their ability to use 
these new skills to manage crises. If the new skills are insufficient they may display 
reduced EE at one assessment, but revert back when they are unable to manage.
If high EE is causal in patient relapse, as argued by Leff and colleagues, then it might 
be expected that patients living in a persistently high EE environment would be more 
likely to relapse than those living in a persistently low EE environment. Those 
relatives in whom EE fluctuates might be expected to show such fluctuations in the 
high direction at the time of relapse.
The present study, by taking advantage of our naturalistic review, aims therefore to 
answer the following questions. How stable is the level of EE over a five year period? 
What are the relapse rates in patients who live in a consistently high, consistently low 
and fluctuating EE environment? What is the pattern of EE at the time of relapse?
METHOD
The identification of schizophrenic patients has been described in detail elsewhere 
(McCreadie, 1982a, McCreadie et al, 1991). Briefly, repeat censuses have identified 
all known schizophrenic patients living in Nithsdale, an historically ancient and 
geographically discrete part of Dumfries and Galloway Region in South West 
Scotland. One such census on 1.8.85 identified 142 schizophrenic patients, all of 
whom had a firm case record diagnosis of schizophrenia, and of whom 68% fulfilled 
the Feighner criteria for probable or definite schizophrenia (Feighner et al, 1972). 
Fifty percent (N = 72) were living with relatives or significant others. Forty nine
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percent of such patients were male (mean age 42 years, standard deviation (SD) 12 
years, range 21-66 years; mean length of illness, as estimated from first hospital 
contact, 14 years, SD 10 years, range 1-40 years) and 51% female (mean age 50 years, 
SD 13 years, range 27-79 years; mean length of illness 18 years, SD 12 years, range 
2-48 years). Forty one percent were living with parents, 42% with a spouse, 4% with 
a child (or children), 6% with an other relative and 7% with a friend. More males than 
females were living with parents. It was 60 such patients and their 70 relatives on 
whom the first of the Nithsdale EE studies focused (McCreadie and Robinson, 1987). 
This examined the prevalence of high EE. A second review of EE took place in 1987 
as part of a screening procedure for a family therapy project (McCreadie et al, 1991). 
By 1990, 34 of the original 60 patients had lived continuously with the same relatives 
in Nithsdale over five years, and had had a firm clinical diagnosis of schizophrenia 
throughout that period. The remainder of the patients no longer fulfilled these criteria 
for various reasons: eight relatives and six patients had died, nine relatives were no 
longer living with the patient, six patients were no longer considered to be 
schizophrenic, and one family had moved away from Nithsdale. Thirty of the 34 
patients had 30 relatives who agreed to be assessed for a third time. The age and 
length of illness of the 30 patients in 1985 were similar to the original cohort of 
patients living with relatives (11 males: mean age 39 years (SD7), mean length of 
illness 11 years (SD7); 19 females: mean age 52 years (SD14), mean length of illness 
18 years (SD12)). The male but not female patients were younger than the total 
Nithsdale cohort. In the latter the mean age of males was 48 years (SD14) and females 
51 years (SD13). The total cohort included 28 long stay inpatients, 19 of whom were 
male.
A psychiatrist (UR), trained in the use of the Camberwell Family Interview (CFI), 
interviewed relatives in their homes over a five month period (April - August 1990). 
Interviews were taped and an assessment made from the recordings. A relative fell
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into the high EE category if he/she made six or more critical comments, showed any 
degree of hostility or had a rating of three or more on emotional overinvolvement 
(EOI) (Leff etal, 1982).
Inter-rater agreement was examined between the three raters of EE in 
1985, 1987 and 1990, all of whom had all been trained in the CFL The third rater 
(LJR) assessed 21 audiotapes, 10 from the 1985 and 11 from the 1987 studies. The 
tapes were of interviews with relatives not assessed in the present study, and of whom 
10 had originally been assessed as showing high EE, and 11 low EE.
As the current study proceeded it was clear to the psychiatrist that one or two elderly 
relatives appeared to be dementing. A brief test of intellectual functioning was 
therefore given to relatives over 65 years of age by one of two psychiatrists (DJH and 
IB) blind to the EE ratings (Hodkinson, 1972).
Relapses over the five year period were determined in two ways as in previous studies. 
Firstly, if a patient was readmitted to inpatient care, his or her case notes were 
scrutinised by a psychiatrist (DJH) blind to the relative's EE rating, and a decision 
made as to whether that admission was the result of an exacerbation of a chronic 
schizophrenic illness or a fresh episode. Secondly, as not all patients who relapse are 
necessarily readmitted to inpatient care, medication prescribed to all schizophrenic 
patients over the five years was determined through examination of medication charts 
and outpatient records. A relapse was deemed to have occurred where the dose of an 
antipsychotic drug was increased by at least 100%, where a patient on no 
antipsychotic medication was then prescribed such a drug, or where another 
antipsychotic drug was added to the pre-existing antipsychotic regime.
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RESULTS
Inter-rater agreement
In 19 of 21 tapes there was agreement as to whether a relative showed high or low EE. 
There was agreement in all tapes about high or low criticism, in 20 tapes about the 
presence or absence of hostility and in 18 tapes about high or low EOI. The 
coefficients ,r, for the correlation between the two pairs of raters for raw scores were 
+0.78 and +0.87 for criticism and +0.74 and +0.92 for EOI. It was not possible to 
estimate correlation coefficients with regard to hostility as in 17 of the 21 tapes both 
raters gave a score of 0, that is, no evidence of hostility.
Stability of EE over five years
Thirty relatives and friends of 30 patients were re-assessed; two fathers, seven 
mothers, eight husbands, five wives, one son, two daughters, two aunts and three 
friends. Included was the assessment of the level of EE in two relatives towards the 
same patient. Also, the level of EE in a mother towards two schizophrenic sons was 
assessed. Thus there were in all 32 EE ratings. EE was high on all three occasions 
(1985, 1987 and 1990) in eight relatives (25%) and low on all three occasions in 12 
relatives (38%). Of the remaining 12 (38%) EE was low in eight relatives on two 
occasions and high on one; in four it was high on two occasions and low on one.
The stability of EE was further examined by considering only those ratings made 
outwith a patient's relapse (see below). Twenty nine relatives had at least two such 
ratings; the ratings showed consistently high EE in seven relatives (24%), 
consistently low in 13 (45%) and fluctuating EE in nine (31%). The corresponding 
results for criticism were high throughout in three relatives (10%) low in 18 (62%) 
and fluctuating in 8 (28%); for hostility 2 (7%), 24 (83%), and 3 (10%); and for EOI
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3 (10%), 16(55%) and 10 (35%). There was no significant difference in the mean 
number of critical comments or degree of EOI in those who had consistently high EE 
when compared with those who showed high but other times low EE.
Two relatives aged over 65 years of age were rated by the mental test score as 
dementing and a third died before formal testing could be carried out. However, she 
had been interviewed for another study at the time of EE assessment by a psychiatrist 
blind to EE status; his clinical opinion was that she had a significant degree of 
dementia. All three had previously been rated as showing high EE (two overinvolved, 
and one both overinvolved and critical). At the third assessment all were rated as 
showing low EE.
Three of the 30 'relatives' were in fact three schizophrenic patients living together, 
namely two sisters and a daughter of one of the sisters. EE relationships on the three 
occasions are shown in Table 3.4.1. Sister (1) and her daughter had relapses over the 
five year period. Both had their level of EE assessed on one occasion at the time of 
their own relapse. Sister (2) had no relapses.
Relapses and EE
Fourteen of the 30 patients (47%) relapsed on 33 separate occasions over five years: 
three of seven patients in a consistently high EE home (mean number of relapses 3.7), 
five of 12 in a fluctuating EE home (mean 3.2) and six of 11 in a consistently low EE 
home (mean 1.1). The eight patients living in a high or fluctuating EE home who 
relapsed did so significantly more frequently than the six living in a consistently low 
EE home (Mann Whitney U test; p < 0.02). The amount of contact between patients 
and relatives was assessed in 1985 and 1987 but not in 1990. Of the seven patients 
living with relatives with consistently high EE, contact between patient and relative 
was high (more than 35 hours per week) in six of the patients on both occasions.
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By chance a rating of a relative's EE was carried out within two months of relapse in 
10 patients (13 relapses in all and thus 13 ratings) (Figure 3.4.1). Three of the 10 
patients were in a consistently high EE home, three in a consistently low EE home and 
four in a fluctuating EE home. Relative's EE was high at the time of eight relapses and 
low at the time of five. As indicated in the introduction, previous research assessed 
patients and relatives only at the acute episode and at follow-up. In order to provide a 
point of contact with this research, results (shown in figure 3.4.1) were extracted for 
six patients and relatives assessed at the time of relapse and at follow-up when not in 
relapse. Three relatives showed low EE on both occasions, two high EE on both 
occasions, and one relative moved from high to low EE. The figure also shows three 
patients and their relatives who were assessed before, at the time of, and after relapse. 
The EE ratings in the first patient were low before, low during and low after; in the 
second, low, high, high; and in the third, low, high, low. In three patients, EE was 
assessed in a relative at the time of two separate relapses. In one patient the relative 
showed high EE on both occasions; in the other two the relative showed high, then 
low EE.
DISCUSSION
As this review was part of a long term project it meant that EE was assessed on the 
three occasions over five years by three different psychiatrists. All three raters, 
however, had been trained in the use of the CFI and an examination of inter-rater 
agreement showed it to be satisfactory. In only two of 21 joint assessments (5%) was 
there disagreement as to whether EE was high or low. A strength of having three 
raters, as opposed to one, was that each was blind to the other ratings; ratings 
therefore were not influenced by previous results.
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Some comment is necessary about the sample of patients and relatives assessed. 
Seventy two of the original 142 schizophrenic patients were living with relatives or 
friends. Sixty of these participated in the first study. At five year follow-up only 34 of 
the original 60 patients were still living with the same relatives, and of these four 
patients had relatives who refused to participate further. The study therefore focused 
on 30 of 142 patients (21%) who had lived continuously with the same relatives and 
friends for five years and whose relatives co-operated with detailed interviews. The 
sample is therefore not typical of the Nithsdale schizophrenic cohort; a bare majority 
of Nithsdale patients live with relatives or friends and a bare majority of those live 
with them for lengthy periods of time.
The level of EE was stable in the majority of relatives when assessed at any time 
(63%) or only outwith patients' relapse periods (69%). It seems therefore that EE in 
most relatives reflects a fixed set of attitudes. On the one hand there are low EE 
relatives who are probably supportive of the patient whatever the circumstances; on 
the other there are high EE relatives who are persistently critical, hostile or 
overinvolved. It is impossible to know of course for how long this fixed set of 
attitudes existed before the first EE assessment. Patients at the time of first 
assessment were in the main in or approaching middle age and had been ill for many 
years. The relative's fixed attitude may be a trait or the outcome of a developmental 
process. If the latter, EE might be less stable during the early years of a schizophrenic 
patient's illness.
In a minority of relatives the level of EE fluctuated and not necessarily only at the time 
of relapse. Such changes may have occurred spontaneously or in reaction to changed 
family circumstances not necessarily involving the patient. The number of patients 
and relatives in this fluctuating category is too small to warrant detailed discussion of 
the possibilities outlined in the introduction and by Kuipers and Bebbington (1988).
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However, relatives could be found to fit most categories; for example, low EE before 
and after relapse, but high at relapse; low before relapse, but high at two subsequent 
relapses; and low before relapse, high at one subsequent relapse, but low at the next.
It has been suggested (Favre et al, 1989) that relatives who show fluctuating EE may 
make fewer critical comments when showing high EE than those who show 
consistently high EE. This was not the case in the present study. It has previously 
been found that even with vigorous family treatment it may not be possible to lower a 
relative's high EE (Leff et al, 1982, 1985, 1989). Perhaps many such relatives would 
fall into the consistently high EE group in the present study. Family treatment may be 
effective in lowering EE mainly in those where spontaneous fluctuations also occur.
It is noteworthy that the onset of dementia was associated in three relatives with a shift 
from high to low EE. Studies of the family life of dementing patients focus especially 
on the damaging effect dementia and its sequelae have on carers; in one respect at 
least the family atmosphere may well have improved in those three families, at least 
from the schizophrenic patients' point of view.
Those schizophrenic patients living together allowed an examination of the level of 
EE in schizophrenics as relatives, not as patients. The complexity of emotional 
expression is illustrated by sister(l), a paranoid schizophrenic patient who showed 
fluctuating levels of EE over time towards both her sister and daughter. At the time of 
her own relapse with a florid delusional and hallucinatory state she showed low EE 
towards her sister and high EE towards her daughter. Sister (2) who had a defect state 
showed consistently low EE towards her niece.
Forty seven percent of patients had at least one relapse over five years. This relapse 
rate is less than in other studies but a community survey such as that carried out in
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Nithsdale is likely to include those with a better prognosis (McCreadie and Phillips, 
1988). Numbers are small but patients who relapsed were divided evenly into those 
living in a consistently high, consistently low or fluctuating EE home. This finding 
over five years is broadly similar to that over one year, described previously 
(McCreadie and Phillips, 1988). However, when patients who did relapse were 
considered separately, those living in a consistently low EE home did so significantly 
less often than those who relapsed and were living in a high or fluctuating EE home. 
This supports the link between relapse and level of EE described elsewhere (Leff et 
al, 1982). Those seven living in a consistently high EE environment fell into two 
groups - four did not relapse at all and three relapsed many times. The former are of 
interest; if high EE is causal in precipitating relapse, then perhaps these patients have 
developed strategies to cope with consistent criticism, hostility or overinvolvement. 
In this context it is noteworthy that Hogarty and colleagues (1986) found that relapse 
rates in patients whose relatives received social therapy and family intervention fell 
without a corresponding fall in high EE. Also, it has been suggested (Leff et al, 1989) 
that diminishing contact between patient and relative might reduce relapse in those 
living with high EE relatives. However, in the present study, six of the seven patients 
who lived in a consistently high EE home were also in high contact with relatives, at 
least over the first two years of the project.
Where the level of EE was assessed at the time of relapse, it was low on five out of 13 
occasions. If EE is causal, other factors must have been operating at the time of 
relapse. Perhaps in these patients life events may be important precipitants of relapse 
(Leff et al, 1973).
We conclude that EE in most relatives is stable over a five year period, and that a 
consistently low level of EE is associated in those patients who do relapse with a 
fewer number of relapses.
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Figure 3.4.1 Pattern of relapse in 10 patients and level of
expressed emotion in their relatives over five years.
Legend
Boxes indicate inpatient admission, vertical lines relapses not leading to inpatient 
admission. Broken horizontal lines connecting boxes or vertical lines indicate a 
clinical judgement that a single relapse has occurred. H=high expressed emotion 
shown by relative; L=low expressed emotion shown by relative.
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TABLE 3.4.1
LEVELS OF EXPRESSED EMOTION 
IN A FAMILY OF SCHIZOPHRENIC PATIENTS
H,
Sister(2)Sister(l)
L5
L, L, L
Daughter
Legend EE has been assessed on three occasions over five years.
H = high EE; L = low EE; arrow indicates direction of EE; circled letter indicates 
that EE was assessed at time of the relative's own relapse.
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MOVEMENT DISORDERS
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4.1 ABNORMAL MOVEMENTS
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SUMMARY
In a review of all known schizophrenic patients (n = 133) from a discrete geographical 
area, Nithsdale in Dumfries and Galloway Region, 88 percent were examined for 
evidence of tardive dyskinesia (TD) and parkinsonism. The prevalence of both TD and 
parkinsonism was 31 percent. The TD group was older and more often showed 
negative schizophrenic symptoms than the non-TD group. The trend was towards a 
higher prevalence among in-patients and Feighner positive schizophrenic patients. 
Parkinsonism was common in patients receiving antiparkinsonian drugs. Ten percent 
of patients had both TD and parkinsonism. The findings will act as a baseline for 
regular reassessments of the population.
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Tardive dyskinesia (TD) is now widely believed to be an important side effect of 
neuroleptics (Anonymous, Lancet, 1979) which are used especially in the treatment of 
schizophrenia. In a recent comprehensive review (Jeste and Wyatt, 1981) the 
prevalence of TD among chronically ill neuroleptic-treated adult psychiatric in-patients 
was estimated at 25.7 percent from studies published between 1976 and 1980. 
However, due to the impact of community care, in-patients probably now form a small 
atypical group of schizophrenic patients (McCreadie, 1982a). To assess the magnitude 
of the problem, community reviews would be more valuable. Out-patient studies of TD 
in schizophrenia are very few; such studies suggest a prevalence of 30-40 percent 
(Chouinard et al, 1979; Smith etal, 1979; Ezrin-Waters et al, 1981).
Parkinsonism, the other principal side effect of neuroleptics has been recognised for 
many years but has recently attracted little attention. One study (Johnson, 1978) found 
the three-monthly prevalence of parkinsonism in patients treated with depot 
neuroleptics to be 24-29 percent.
To further our knowledge about prevalence rates for both these movement disorders 
and to obtain a baseline for follow-up studies, a review of such side effects in the vast 
majority of all known schizophrenic patients, including in-patients, from a discrete 
geographical area has been carried out.
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METHOD
The geographical area from which the patients were drawn, Nithsdale in Dumfries and 
Galloway Region, the identification of such patients, and the social, demographic and 
clinical information obtained have been described elsewhere (McCreadie, 1982a). On 
1 March 1981 there were 133 schizophrenics, of whom 28 percent were in-patients, 17 
percent day patients and 32 percent out-patients; 23 percent were attending only their 
general practitioner. All in-patients, day patients and out-patients, and 46 percent of 
general practice patients (n = 117, 88 percent of the total population) were examined for 
evidence of TD using the Abnormal Involuntary Movements Scale (AIMS) (US 
Department of Health, Education and Welfare, 1976) and of parkinsonism, using the 
Targeting Abnormal Kinetic Effects (TAKE) scale (Wojcik et al, 1980); both examine 
individual areas of the body, following which a global assessment is made. The 
assessments were made during a four-week period by three psychiatrists who took part 
in several practice sessions before the study began. Forty-one percent of the subjects 
were examined independently by different combinations of two of the three 
psychiatrists to assess inter-rater agreement.
Of those examined, 20 percent were not currently receiving neuroleptics, but in only 
seven patients (6 percent) was there no record of such drugs being prescribed in the 
past. Thirty-three percent were receiving anti-parkinsonian drugs. No attempt was 
made to assess for how long patients had received neuroleptics or how much had been 
prescribed throughout the course of the illness; such information would probably have 
been inaccurate, especially for out-patients and patients attending only their general 
practitioner.
Differences between groups were tested by the chi-square test (two-tailed tests 
throughout).
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RESULTS
Inter-rater agreement on the five-point global scales (0 = none to 4 = severe) was 
complete or partial (a difference of only one point) in 90 percent of assessments for TD 
and 94 percent for parkinsonism.
Tardive dyskinesia
The prevalence and severity of TD as shown by the global and individual scales are 
given in Table 4.1.1. If patients with at least a rating of 'mild' on the global scale are 
considered to have definite TD, then the prevalence is 31 percent. The areas affected 
most were the lips, jaw and tongue.
When patients with and without definite TD were compared on the basis of 
demographic, social and clinical data only the following statistically significant 
differences were found. Patients with TD were older (P < 0.001), had been ill longer (P 
< 0.02) and spent a longer time as in-patients (P < 0.02). These three factors are no 
doubt intimately related. More of them showed flattening of affect (P < 0.05), were 
socially withdrawn (P < 0.05 and needed supervision of their personal appearance (P < 
0.05). Trends, which failed to reach statistical significance, were that TD was more 
common in in-patients than in other groups (45 percent versus 25 percent), and in 
Feighner positive (Feighner et al, 1972) than Feighner negative schizophrenic patients 
(38 percent versus 13 percent).
Parkinsonism
The prevalence and severity of parkinsonism are shown in Table 4.1.2. When a rating 
of at least 'mild' on the global severity scale is taken as evidence of definite 
parkinsonism the prevalence is 31 percent. Prevalence rates for bradykinesia, rigidity
104
and tremor were broadly similar. When patients with and without definite 
parkinsonism were compared the only statistically significant difference was that 
patients with parkinsonism were aware of such side effects (P < 0.001).
Twelve patients (33 percent of both the TD and parkinsonism groups) had symptoms of 
at least mild TD and parkinsonism. This proportion was similar to that found in the 
parent group.
Among variables which did not help to differentiate patients with either TD or 
parkinsonism from others were the patient's sex and current neuroleptic or anti­
parkinsonian medication. Thirty-eight percent of patients receiving anti-parkinsonian 
drugs had parkinsonism. Seven patients with TD and six with parkinsonism were not 
receiving neuroleptics; the mean age of the TD group was 75 years, the parkinsonian 
group 76 years. There was no record of two patients in the TD group and four in the 
parkinsonian group ever having received neuroleptics.
DISCUSSION
Although the prevalence figure we obtained for tardive dyskinesia, 31 percent, 
compares broadly with findings in other studies, the plethora of rating scales used to 
assess TD (Gardos et al, 1977) makes an accurate comparison impossible. In the 
present study, patients with tardive dyskinesia include those with withdrawal 
dyskinesia and those with spontaneous non-drug-related dyskinesia, estimated to be 
present in one quarter of patients with persistent dyskinesia (Jeste and Wyatt, 1981). 
Spontaneous dyskinesia is said to be more common in the aged, and it is noteworthy 
that the mean age of patients in the present study with TD, but not currently receiving 
neuroleptics was 75 years.
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The findings that the prevalence of TD in in-patients tended to be higher than in other 
groups suggests that the examination of only in-patients may paint an unduly 
pessimistic picture. The difference in prevalence rates is probably due to the fact that 
in-patients are significantly older (McCreadie, 1982a); advancing age is one of the few 
factors shown consistently to produce an increased risk of TD (Smith and Baldessarini, 
1980). Also, in-patients are more disabled in terms of the negative symptoms of 
schizophrenia such as flattening of affect (McCreadie, 1982a) which, in turn, were 
more commonly found in patients with TD. This association between TD and negative 
schizophrenic symptoms has been reported previously where the factors of age and sex 
were controlled (Ital et al, 1981). The patients with prominent negative symptoms 
belong to the Type 2 syndrome of schizophrenia (Crow, 1980) where organic brain 
damage may be an important aetiological factor. Perhaps these patients run a greater 
risk of developing TD.
The trend towards TD being more common in Feighner positive than in Feighner 
negative schizophrenic patients may also be due to the fact that the former were older 
and had been ill longer (McCreadie, 1982a).
Parkinsonism was common in patients receiving anti-parkinsonian drugs. The value of 
such medication given continuously to patients receiving neuroleptics has long been 
questioned (Mindham et al, 1972). It may be, of course, that the prevalence and 
severity of parkinsonism would have been even greater if the patients had not been 
receiving such drugs. Also, parkinsonism was found in a small number of aged patients 
(average age 76 years) not receiving neuroleptics. It is possible some of these patients 
had developed idiopathic parkinsonism.
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In a small group of patients, parkinsonism and TD co-existed. If parkinsonism is due to 
dopamine receptor blockade and TD to dopamine receptor supersensitivity (Marsden 
and Jenner, 1980) it is hard to understand how both conditions can exist in the same 
patient at the same time, unless the two processes are mediated through different 
dopamine systems.
The present study will act as a baseline for regular reassessment of the population. The 
members of the population will change as new patients develop the illness or move to 
Nithsdale, while others move away from the area or die. It will be valuable to learn 
whether tardive dyskinesia and parkinsonism will increase further in the community or 
whether, now that neuroleptics have been available to a generation of schizophrenic 
patients, the prevalence of these side effects has reached a plateau.
In conclusion this community survey, the first of its kind has identified a high 
prevalence of both TD and parkinsonism. This illustrates well the cost to schizophrenic 
patients of taking neuroleptics. Such drugs are effective in controlling the positive 
symptoms of the disorder (Crow, 1980), but the price to be paid is considerable.
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TABLE 4.1.1
PERCENTAGE OF PATIENTS SHOWING TARDIVE DYSKINESIA (N = 117)
Absent Doubtful Mild Moderate Severe
Global rating 48 21 26 4 1
Face 92 4 4 0 0
Lips 69 14 16 1 0
Jaw 71 15 10 4 0
Tongue 67 14 18 1 0
Upper limbs 84 7 8 0 1
Lower limbs 85 9 6 0 0
Trunk 94 2 3 1 0
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TABLE 4.1.2
PERCENTAGE OF PATIENTS SHOWING PARKINSONISM (N = 117)
Absent Doubtful Mild Moderate Severe
Global rating 39 30 29 2 0
Bradykinesia 54 17 27 2 0
Rigidity 68 11 20 1 0
Tremor 62 15 21 2 0
Akathisia 96 2 2 0 0
Autonomic symptoms 
(e.g. salivation)
92 4 4 0 0
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4.2 HANDEDNESS AND TARDIVE DYSKINESIA
r  g  McCr e a d ie  
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SUMMARY
Handedness was assessed in 87 percent (n = 116) of all known schizophrenic patients 
from a discrete geographical area, Nithsdale in Dumfries and Galloway Region. 
Seventy-three percent were right-handed, a proportion greater than that found in a 
normal population. It was especially Feighner positive schizophrenics and non-in- 
patients who produced the excess of right-handers. Within the Feighner positive group, 
68 percent of mixed or left-handers, but only 29 percent of right-handers had tardive 
dyskinesia.
I l l
There have recently been several conflicting reports about whether there is an excess of 
right or left-handedness amongst schizophrenic patients, or whether the distribution is 
similar to that found in the general population (e.g. Lishman and McMeekan, 1976; 
Taylor et al, 1980; Chaugule and Master, 1981). Different ways of classifying 
handedness and defining schizophrenia may have given rise to some of the confusion. 
Also, former studies have examined only in-patients, who now probably form a small 
atypical group of schizophrenic patients (McCreadie, 1982a). The present study 
reports, firstly, handedness patterns in the vast majority of all known schizophrenic 
patients from a discrete geographical area, and secondly, an association between 
handedness and tardive dyskinesia (TD).
METHOD
The geographical area from which patients were drawn, Nithsdale in Dumfries and 
Galloway Region, the identification of such patients, and the demographic, social and 
clinical information obtained have been described elsewhere (McCreadie, 1982a). On 
1 March 1981 there were 133 schizophrenic patients, of whom 28 percent were in­
patients, 17 percent day patients, and 32 percent out-patients; 23 percent attended only 
their general practitioners. All in-patients (except one who was uncooperative), day 
patients and out-patients and 46 percent of general practice patients (n = 116) were 
assessed for handedness using the Annett Questionnaire (Annett, 1970). Patients were 
asked to perform 11 tasks: writing, throwing a ball, holding a tennis racket, holding a 
match to strike it, hammering, using a toothbrush, using scissors, guiding thread 
through the eye of a needle, holding a broom, dealing cards, and unscrewing a lid from 
a jar. A twelfth task, using a shovel, was omitted as it is interchangeable with holding a 
broom (Annett, 1970). The necessary equipment to perform each task was placed in 
front of the patient equidistant from his hands. The broad classification of handedness 
of Fleminger and his colleagues (1977) was used. A patient was defined as right­
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handed if the right-hand was used for all activities, mixed-handed if the right-hand was 
used for writing and the left-hand for one or more of the other activities, and left- 
handed if the left-hand was used for writing.
Full details of the assessment of TD are given elsewhere (McCreadie et al, 1982a). 
Briefly, TD was assessed by the Abnormal Involuntary Movements Scale (AIMS) (US 
Department of Health, Education and Welfare, 1976), and a patient was defined as 
having TD if he or she had a rating of at least 'mild' on the global scale.
The psychiatrist who examined the patients for TD were different from the ones who 
carried out the handedness test, except in the case of general practice patients (n = 14), 
all assessments on whom were carried out by the senior psychiatrist (R.G.McC).
Differences between groups were tested by the chi-square test (two-tailed tests 
throughout).
RESULTS
Table 4.2.1 shows the distribution of handedness for the total population, and also 
according to age and whether the patients belonged to the Feighner positive ('definite' 
or 'probable') or negative category (Feighner et al, 1972). It also includes the 
distribution of handedness in a large normal population aged 16-64 years (Fleminger et 
al, 1977). Seventy-three percent of the schizophrenic patients were right-handed, 23 
percent mixed-handed, and 4 percent left-handed. When compared with the normal 
population, there were significntly more right-handers in the Feighner positive group in 
both the under 40 years and the 40-64 years age groups (86 percent versus 44 percent, P
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< 0.001; 78 percent versus 56 percent, P < 0.02). Statistically significant differences 
were not found between the Feighner negative schizophrenic patients and normal 
subjects.
When a comparison was made of the distribution of handedness in in-patients and non­
in-patients (Table 4.2.2) within the Feighner positive group, there were significantly 
more right-handers among the non-in-patient population (Table 4.2.2; 85 percent 
versus 64 percent, P < 0.05).
Right-handers (dextrals) were compared on the basis of demographic, social and 
clinical data with those who were left-handed or of mixed-handedness (non-dextrals). 
An analysis was carried out separately for the Feighner positive and negative groups. 
The only statistically significant difference was in the proportion of patients in the two 
groups with TD (Table 4.2.3). Sixty-eight percent of Feighner positive non-dextrals, 
but only 29 percent of dextrals, had TD (P < 0.01). The difference was not apparent in 
the Feighner negative group. A trend, not statistically significant, was that within the 
Feighner positive group, non-dextrals showed more flatness of affect and poverty of 
thought.
DISCUSSION
The decision to compare handedness patterns between Nithsdale schizophrenic patients 
and normal subjects needs further comment. It may be argued that cultural differences 
between Nithsdale and London (from which the normal subjects were taken) might 
explain some of the results. Child rearing practices in a largely rural, conservative area 
might have been directed towards the use of the right-hand in all activities. However,
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only one half of the schizophrenic patients were born in Nithsdale and there were no 
differences in handedness patterns between schizophrenic patients bom in Nithsdale 
and those born elsewhere. It must also be pointed out that, in the survey of normals, 
subjects completed a questionnaire but were not asked to perform any of the items. 
Self-reports of handedness can lead to over-reporting of left-handedness (Satz et al, 
1967). Furthermore, in the study of normals, the option of 'either hand1 was given; an 
'either' response was grouped with the left responses. In the present study the hand 
used to carry out the action was taken to be the preferred hand. Thus there might be a 
small bias in the present study towards finding a greater number of dextrals. It is most 
unlikely, however, that this bias would explain the marked difference found in the 
proportion of dextrals in the Feighner positive group compared with the normal 
subjects. The proportion in the Feighner positive population, 78 percent, is somewhat 
greater than that found in another study which also found an excess of right-handers, 64 
percent (Taylor et al, 1980). That study, which also examined Feighner positive 
patients but confined itself to in-patients, asked only some patients to perform all tasks, 
and included 'either' responses.
A recent study (Chaugule and Master, 1981) which used the same classification of 
handedness as in the present study but which used a different definition of 
schizophrenia (ICD-8; WHO, 1974) found an excess of non-dextrals. Other studies 
(e.g. Gur, 1977; Nasraliah et al, 1981) which found an excess of non-dextrals among 
schizophrenic patients examined only in-patients and did not use either the 
classification of handedness or the definition of schizophrenia employed in the present 
study. The way in which schizophrenia is defined is probably crucial. This is shown in 
the present study by the fact that in Feighner negative schizophrenic patients, who 
nonetheless had a firm case record diagnosis of schizophrenia, the distribution of 
handedness patterns was not significantly different from that in normal subjects. It
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appears that the excess of right-handers is to be found especially among the more 
chronically ill patients.
Possible reasons for an excess of dextrals in a schizophrenic population have been 
discussed fully elsewhere (Taylor et al, 1980). Briefly, Taylor and her colleagues 
postulate that the more dominant one hemisphere is, the more vulnerable that individual 
will be to disease or injury. Full right-handedness correlates with strong left 
hemisphere dominance for language skills, while mixed or left-handedness is more 
likely to be associated with bilateral, albeit still unequal, representation of language 
function.
One possible explanation of the excess of right handers among Feighner positive non­
in-patients suggests itself if the results are looked at from another direction, namely, 
that relatively more non-dextrals were found among in-patients. In-patients who have a 
greater prevalence of negative symptoms (McCreadie, 1982a) belong especially to the 
Type 2 Group of schizophrenic patients (Crow, 1980) where organic brain disease is 
thought to be an important aetiological factor. Could it be that some cerebral insult has 
both shifted natural dextrals towards non-dextrality and predisposed schizophrenic 
patients to the development of negative symptoms? Might this also explain the high 
prevalence of tardive dyskinesia amongst non-dextrals, as brain damage might render 
patients more susceptible to the side effects of prolonged administration of 
neuroleptics, now widely accepted as the main aetiological factor in tardive dyskinesia 
(Anonymous, Lancet, 1979)? This interpretation of the data is highly speculative and, 
as yet, we have no convincing explanations of our results.
If the unexpected association between tardive dyskinesia and non-dextrality can be 
confirmed in other, larger studies, then assessment of handedness may be a useful 
predictive test of tardive dyskinesia in schizophrenic patients. If a patient is non- 
dextral, caution in the prescription of neuroleptics may be necessary.
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TABLE 4.2.1
DISTRIBUTION OF HANDEDNESS
Nithsdale schizophrenic patients
Total Feighner Feighner Normal
positive negative subjects*
schizophrenic schizophrenic
patients patients
N % N % N % N %
Under 40 years of age: 
Right 35 78 30 86 5 50 189 44
Mixed 9 20 4 11 5 50 195 46
Left 1 2 1 3 0 0 44 10
Total 45 100 35 100 10 100 428 100
40 - 64 years of age: 
Right 41 75 28 78 13 68 207 56
Mixed 10 18 6 17 4 21 139 37
Left 4 7 2 5 2 11 26 7
Total 55 100 36 100 19 100 372 100
65 years and over: 
Right 9 56 8 57 1 50 _  _
Mixed 7 44 6 43 1 50 -
Left 0 0 0 0 0 0 -
Total 16 100 14 100 2 100 _
All ages: 
Right 85 73 66 78 19 61 392 49
Mixed 26 23 16 19 10 32 336 42
Left 5 4 3 3 2 7 72 9
Total 116 100 85 100 31 100 800 100
* Taken from Fleminger et al (1977)
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TABLE 4.2.2
HANDEDNESS IN IN-PATIENTS AND NON-IN-PATIENTS
Handedness
Feighner positive 
schizophrenic patients
Feighner negative 
schizophrenic patients
In-patients Non-in-patients In-patients Non-in-patients
n % n % n % n %
Right 19 64 47 85 4 57 15 63
Mixed 10 33 6 11 3 43 7 29
Left 1 3 2 4 0 0 2 8
Total 30 100 55 100 7 100 24 100
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TABLE 4.2.3
HANDEDNESS AND TARDIVE DYSKINESIA
Feighner positive schizophrenic Feighner negative schizophrenic
patients patients
Dextrals Non-dextrals Dextrals Non-dextrals
n % n % n % n %
Tardive dyskinesia 19 29 13 68 3 16 1 8
No tardive dyskinesia 47 71 6 32 16 84 11 92
Total 66 100 19 100 19 100 12 100
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4.3 FOLLOW-UP OF TARDIVE DYSKINESIA AT 3V2 YEARS
A D T ROBINSON 
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SUMMARY
The point-prevalence of tardive dyskinesia in schizophrenic patients from a discrete 
geographical area (Nithsdale, in Dumfries and Galloway Region) in 1981, 1982, and 
1984 was 31%, 27% , and 33% respectively. This suggests that the prevalence of 
tardive dyskinesia in a community of schizophrenic patients has reached a plateau. In 
12% of patients there was persistent dyskinesia, i.e. abnormal involuntary movements 
were present at all three assessments. Persistent dyskinesia was more common in older 
patients. The severity of tardive dyskinesia fluctuated between assessments in 41% of 
patients, indicting that it is only a transient feature in some cases.
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A previous study of tardive dyskinesia (TD) in all known schizophrenic patients in 
Nithsdale, an historically ancient and geographically discrete part of Dumfries and 
Galloway Region, found a point-prevalence of 31% (McCreadie et al, 1982a); an 
interim review one year later found a prevalence of 27% (Barron & McCreadie, 1983). 
It was suggested that as a generation of schizophrenic patients has now been exposed to 
neuroleptics, which are thought to be the main aetiological factor in TD (Anonymous, 
Lancet, 1979), the community prevalence might have reached a plateau. To determine 
whether this may be so, the present study examined Nithsdale schizophrenic patients 
3Vi years after the initial census. It also identified and described patients with persistent 
dyskinesia.
METHOD
The 1981 census
The original census, carried out in March 1981, identified all known schizophrenic 
patients in Nithsdale. Included in the survey were all in-patients, day-patients, and out­
patients of Crichton Royal Hospital who on 1 March 1981 had a firm case-record 
diagnosis of schizophrenia and whose home address was in Nithsdale. In addition, all 
the general practitioners in the area replied to our questionnaire and identified 
schizophrenic patients known to the practice and receiving treatment. The Feighner 
criteria for schizophrenia (Feighner et al, 1972) were applied to each patient. The 
census identified 133 schizophrenic patients, 117 of whom were examined for tardive 
dyskinesia.
3V6 year follow-up
The repeat census was carried out 3V£ years later (20 August, 1984) in a similar way to
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the initial survey. It identified 145 schizophrenic patients, of whom 70% fulfilled the 
Feighner criteria for definite or probable schizophrenia, and 88 (61%) were members of 
the original cohort: 17% were in-patients, 24% day-patients, 39% out-patients or
supervised by a community psychiatric nurse (CPN), and 20% were attending only 
their family doctor.
We examined 130 of the schizophrenic patients (90%) for evidence of tardive 
dyskinesia - all the in-patients, all the day-patients except one, all the out-patients 
except one, all the CPN patients and 57% of the general-practice patients. To assess 
TD, we used the Abnormal Involuntary Movements Scale (AIMS) (US Department of 
Health, Education and Welfare, 1976), in which individual areas of the body are 
examined and then a global assessment is made: this ranges from 0 (no movements) 
through 1 (minimal), 2 (mild), and 3 (moderate), to 4, 'severe movements'. The 
assessments exclude tremor, akathisia, and dystonia. Our assessments were made 
during a 6 week period by two psychiatrists, and 12% of patients were examined 
independently by both psychiatrists to assess inter-rater reliability.
Of those examined, 16% were not currently receiving neuroleptics, but only 5 patients 
(4%) had no record of such drugs having been prescribed in the past; 27% were 
receiving anti-parkinsonian drugs. The length of time for which patients had been 
receiving neuroleptics since the initial census and the route of drug administration were 
determined; no attempt was made to estimate the total quantity of medication 
prescribed, as such information would probably have been inaccurate, especially for 
out-patients and general-practice patients.
Differences between groups were tested by the chi-square test.
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RESULTS
Inter-rater reliability on the 5-point global AIMS scale was high (Spearman rank 
correlation coefficient r = +0.82, P < 0.01).
1984 prevalence of abnormal movements
If patients with a rating of at least 'mild' on the global AIMS scale are considered to 
have definite TD, then the prevalence is 30% (Table 4.3.1): 18% with only oro-facial 
movements, 3% with trunk and/or limb movements, and 9% with both oro-facial and 
distal movements.
Persistent dyskinesia
Of the 145 patients, 88 (61%) had been examined on all three occasions. The 
prevalence figures for definite TD in this subgroup in 1981, 1982, and 1984 were 35%, 
32%, and 30% respectively (Table 4.3.1). Almost half (47%) of the subgroup had 
never shown signs of dyskinesia; 12% had dyskinesia on all three occasions 
('persistent dyskinesia'); and 41% had dyskinesia on at least one but not three occasions 
('fluctuating dyskinesia'). In the 'fluctuating' group, the severity of dyskinesia 
increased over time in 11% of cases, decreased in 17%, and showed no trend in 13%. 
The details of these changes are presented in Table 4.3.2.
Patients with persistent dyskinesia were compared with those who had never had 
abnormal movements, on the basis of sex, age, hospitalisation status, Feighner 
categorisation, and medication (current and previous, antipsychotic and anti­
parkinsonian). There were no statistically significant differences between the two 
groups, although the trend was that patients in the persistent dyskinesia group were 
older (mean age 51 years vs 45 years) and more often in-patients or day patients (73% 
vs 44%).
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In the group with fluctuating dyskinesia, when those with worsening TD were 
compared with patients showing decreasing TD, there were no statistically significant 
differences in the clinical, social, and demographic characteristics outlined above. In 
particular, there was no clear relationship between the starting or stopping of anti­
psychotic or anti-parkinsonian medication and fluctuation in dyskinesia. However, the 
trend was that patients with worsening TD were younger (mean age 51 years vs 61 
years).
Of those with persistent dyskinesia, 9% had only oro-facial movements and 91% both 
oro-facial and distal movements.
DISCUSSION
The point-prevalence of TD in all known schizophrenic patients from a given 
geographical area, assessed on three separate occasions spread over 3Vi years, has 
remained fairly constant between 27% and 31%. It is probable, therefore, that the 
community prevalence has indeed reached a plateau, and is not likely to increase 
further with time. As new patients develop schizophrenia and are given neuroleptics, 
some will develop dyskinesia. These will be balanced in numbers by others dying or 
recovering from the illness; in the latter group, medication will probably be stopped. 
The plateau in the present series of studies contrasts sharply with the reported increase 
in prevalence during the 1970s. As anti-psychotic medication was widely prescribed at 
that time, the supposed increase in prevalence probably reflects clinicians' increasing 
awareness of the condition: the true prevalence may well have been essentially
unchanged throughout.
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Interpretation of our results is complicated by the finding that although about a third of 
the patients had TD at any given time, only 12% of those patients rated on all three 
occasions had persistent dyskinesia. This latter figure is probably a more accurate 
assessment of the severity of the problem: point-prevalence figures include mild and 
reversible TD, and paint too gloomy a picture. Schizophrenic patients with persistent 
dyskinesia tended to be older than those with no TD: age is the only factor consistently 
found to be associated with TD (Smith et al, 1979; Seeman, 1981; Kane & Smith, 
1982; Barnes etal, 1983).
Forty one percent of patients examined on all three occasions had TD on one or two, but 
not all three occasions. There are no doubt several reasons for fluctuating dyskinesia 
(reviewed by Bergen et al, 1984). Deficiencies in assessment, such as within-rater 
variability (Bergen et al, 1984), lack of sensitivity of the rating scale (Bames, 1984), or 
lack of standardisation of rating schedules in relation to time of depot neuroleptic 
administration (Barnes & Wiles, 1983) may be important. It is unlikely, however, that 
these methodological problems can entirely explain fluctuating dyskinesia: the present 
findings therefore emphasise the transient nature of TD in some patients. In the present 
study, worsening dyskinesia over time was more common in young patients. Such 
patients had probably had a shorter exposure to neuroleptics, which had not yet 
produced their maximum effect; as the years go by, dyskinesia may be expected to 
worsen in them.
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TABLE 4.3.1
POINT PREVALENCE OF ABNORMAL INVOLUNTARY MOVEMENTS 
AMONG SCHIZOPHRENIC PATIENTS IN NITHSDALE (1981, 1982, 1984)
Abnormal movements 
(AIMS score)
1981 1982 1984
All patients Subgroup* 
(N = 117) (N = 88)
All patients Subgroup* 
(N = 122) (N = 88)
All patients Subgroup* 
(N = 130) (N = 88)
Mild/moderate/severe
Nil/minimal
31% 35% 
69% 65%
27% 32% 
73% 68%
30% 30% 
70% 70%
* Subgroup: patients rated on all three occasions
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TABLE 4.3.2
PATTERNS OF PRESENCE/ABSENCE OF ABNORMAL INVOLUNTARY 
MOVEMENTS IN A GROUP OF 88 SCHIZOPHRENIC PATIENTS ALL OF WHOM 
WERE ASSESSED IN 1981, 1982 AND 1984
1981 1982 1984 n (%)
Absent Absent Absent 41 (47)
Absent Absent Present 4 (4)
Absent Present Present 6 (7)
Absent Present Absent 6 (7)
Present Absent Present 5 (6)
Present Absent Absent 10 (11)
Present Present Absent 5 (6)
Present Present Present 11 (12)
88(100)
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4.4 AKATfflSIA, PARKINSONISM, TARDIVE DYSKINESIA 
AND PLASMA NEUROLEPTIC LEVELS
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SUMMARY
Eighty eight percent (N = 146) of all known schizophrenic patients living in 
Nithsdale, South-West Scotland were examined for the presence of the three 
principal movement disorders secondary to antipsychotic medication, namely 
akathisia, tardive dyskinesia and parkinsonism. Eighteen percent had akathisia, 5% 
pseudoakathisia, 29% tardive dyskinesia, 8% persistent tardive dyskinesia, and 27% 
parkinsonism. Forty four percent had no movement disorder, 36% had one and 20% 
more than one movement disorder. Plasma neuroleptic levels at the time of clinical 
assessment were measured by the radioreceptor technique. Correlations between 
dose and plasma level were low; the ratio mean plasma concentration: mean dose 
was greatest with fluphenazine decanoate and lowest for sulpiride. The 
concentration:dose ratio was higher in the elderly. There was no relationship 
between neuroleptic levels and akathisia, parkinsonism or tardive dyskinesia. 
Additional psychotropic medication influenced neuroleptic levels. In 9% of patients 
receiving oral antipsychotic medication no drug was detected in plasma.
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At any given time the majority of schizophrenic patients are living outside hospital. 
Such 'community care' has been made possible especially by the use of maintenance 
antipsychotic drug therapy. Such drugs however can produce marked side effects, 
especially movement disorders. A previous survey (McCreadie et al, 1982a) 
estimated the community prevalence of both drug-induced parkinsonism and tardive 
dyskinesia (TD) to be 31%. However, a third movement disorder secondary to 
antipsychotic medication, namely akathisia, has been little studied.
Akathisia is a long recognised side effect (Steck, 1954), is distressing and can lead to 
poor drug compliance (Van Putten, 1974). Its incidence in patients prescribed 
neuroleptics was initially reported as 21% (Ayd, 1961) but this study included 
patients now recognised as having orofacial dyskinesia. Two more recent studies 
(Van Putten, 1975, Braude et al, 1983) found incidences of 45% and 25%, the latter 
in patients admitted to acute admission wards. Individual neuroleptics may cause 
different rates of incidence; for example haloperidol produced akathisia in 75% of 
patients (Van Putten et al, 1984). Satisfactory prevalence studies are even fewer. 
'Motor restlessness' was found in 30% of chronic hospitalised schizophrenic patients 
receiving trifluoperazine (Kennedy et al, 1971) but this study did not assess 
subjective restlessness, considered to be a cardinal feature of the disorder. Thirty- 
five and 41% of chronic schizophrenic patients attending outpatient clinics and 
receiving intra- muscular antipsychotic drugs (Barnes and Braude, 1985, Gibb and 
Lees, 1986) and 19% of chronic schizophrenic inpatients (Barnes, 1989) had 
akathisia.
We report the findings of what is to our knowledge the first community survey of the 
prevalence of akathisia in schizophrenic patients. The relationship between 
akathisia, TD and parkinsonism is also examined. The survey thus assesses the 
prevalence of the three principal movement disorders and quantifies the 'cost' to the 
patient, in terms of side effects, of antipsychotic drug treatment.
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It has also been suggested that high plasma neuroleptic levels are associated with the 
three movement disorders (e.g. Hansen et al, 1982). The present study examines 
further the relationship between akathisia, parkinsonism and TD and plasma 
neuroleptic levels.
METHOD
The identification of schizophrenic patients has been described elsewhere 
(McCreadie, 1982a). Briefly, repeat censuses since 1981 in Nithsdale, an 
historically ancient and geographically discrete part of Dumfries and Galloway 
Region in South-west Scotland, have identified all known schizophrenic patients - 
inpatients, daypatients, outpatients, patients supervised by community psychiatric 
nurses and patients known only to their family doctor. A repeat census on 11 
September 1989 identified 165 patients, it was these on whom the present study 
focussed.
Patients were examined in three ways: firstly for the presence of akathisia through 
the use of the Barnes akathisia scale (Barnes, 1989); secondly for TD through the 
Abnormal Involuntary Movements Scale (AIMS) (US Department of Health, 
Education and Welfare, 1976) and thirdly for parkinsonism through the Simpson and 
Angus scale (Simpson and Angus, 1970). Assessments were made over the three 
months following the census date by two psychiatrists who took part in several 
practice sessions before the study began. Twenty patients were assessed by both 
psychiatrists to measure inter-rater agreement.
A blood sample was also taken to measure the plasma neuroleptic level by the radio­
receptor technique (Krska et al, 1986), using sheep caudate instead of calf. Samples 
were assayed in duplicate and individual sample blanks were subtracted.
132
Inter-assay accuracy and precision (percent of known concentration + CV) obtained 
by repeated analysis of known concentrations of haloperidol were: 106.6 + 10.3, 
99.9 + 23.7, 96.8 + 17.1, 100.9 + 8.3 and 98.0 + 7.1 for 20, 50, 100, 200 and 500 nM 
solutions respectively. Results are expressed as Units of Neuroleptic Activity 
(UNA) where one UNA is equivalent to the activity of a 1 nM solution of 
haloperidol.
In some cases it was possible to take the blood sample immediately before the 
morning dose if the patient was receiving oral medication or immediately before a 
depot injection if the patient was receiving intra-muscular medication. In others the 
blood sample was random in relation to medication, but in all cases samples were 
taken at the time of clinical assessment. A record of all current psychotropic 
medication was made. Doses of neuroleptics were converted to chlorpromazine 
equivalents, through published tables (Davis, 1985) and estimates (lOOmg 
chlorpromazine, 1.6mg pimozide, 2mg oral flupenthixol, lOmg oral clopenthixol, 
200mg sulpiride, 75mg remoxipride).
RESULTS
All 165 patients had a firm case record diagnosis of schizophrenia. Nineteen patients 
(12%) were not examined: 12 refused (2 inpatients, 1 day patient, 3 outpatients, 2 
patients supported by community psychiatric nurses and 4 others); access in a 
further three was refused by general practitioners; and four were not approached 
(one patient was in a terminal care ward and three patients known only to their 
general practitioner had refused to take part in previous Nithsdale surveys). Thus 
146 patients (88%) were assessed. Their mean age was 50 years (standard deviation 
(SD) 15, range 20-82). Social and demographic data are shown in Table 4.4.1.
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When DSM-IU-R criteria (American Psychiatric Association, 1987) were applied to 
case records 74% were schizophrenic, 8% had delusional disorder, 3% 
schizophreniform disorder and 6% schizoaffective disorder; 9% could not be 
categorised. At the time of clinical assessment 88% were receiving antipsychotic 
medication; of these, 50% were receiving oral, 34% longacting intra-muscular and 
16% both oral and intra-muscular medication. Six percent of in- and day-patients 
and 14% of others were not receiving antipsychotic medication.
Akathisia
The Barnes scale gives a global rating of akathisia ranging from absent through 
questionable, mild, moderate and marked to severe. Observation of movements 
characteristic of akathisia in the absence of a subjective report of inner restlessness 
or compulsive desire to move the legs is classified as pseudoakathisia. In 19 of the 
20 patients rated by both psychiatrists there was complete agreement on the global 
scale. If a rating of mild or more is taken as definite akathisia, then 18% had 
akathisia and a further 5% pseudoakathisia (Table 4.4.2). Those with definite 
akathisia (N = 27) were compared on social, demographic and clinical data with 
those with no akathisia (N = 98) (the 'questionable' and pseudoakathisic groups were
excluded). The only statistically significant difference was that those with akathisia
2
were more often inpatients or daypatients (x = 8.75, P < 0.01).
There was a trend, not statistically significant, for parkinsonism to be more common 
in akathisic patients (41% vs 22%).
Tardive dyskinesia
Probable TD was diagnosed if there were at least "moderate" abnormal involuntary 
movements in one or more body areas or at least "mild" movements in two or more
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areas (Schooler and Kane, 1982). In 17 of the 20 patients rated by both psychiatrists 
there was agreement as to whether TD was absent or probable. Probable TD was
diagnosed in 42 (29%) patients (Table II). Those with probable TD when compared
2 2 with those with no TD were older (x = 7.43, P < 0.01), had been ill longer (x = 4.17,
P < 0.05) and more often were on long acting intra-muscular antipsychotic
2
medication (x = 5.00, P < 0.05).
Four of the seven patients with pseudoakathisia had at least mild TD of the trunk or 
extremities.
Sixty one of the 146 patients had been assessed for the presence of TD on two 
previous occasions, 1981 and 1984 (McCreadie et al , 1982a, Robinson and 
McCreadie, 1986). Of the 61, 32 (53%) had never shown TD, 24 (39%) showed TD 
on at least one occasion, and 5 (8%) showed TD on all three occasions. Of the 14 
patients who had TD in 1981, six had it in 1989.
Parkinsonism
As recommended by Simpson and Angus (1970) a score of more than 0.3 was taken 
as evidence of parkinsonism. In 18 of the 20 patients rated by both psychiatrists 
there was agreement as to the presence or absence of parkinsonism. Of the 146 
patients, 39 (27%) had parkinsonism (Table 4.4.2).
Patients who had parkinsonism when compared with those who had not were older
2 2 
(x = 9.97, P < 0.01) were more often inpatients or daypatients (x = 9.02, P < 0.01),
2had been ill longer (x = 5.54, P < 0.02) and were more often on intra-muscular 
antipsychotic medication (x = 4.46, P < 0.05). Twenty two percent of patients 
without, and 34% with parkinsonism, were receiving antiparkinsonian medication.
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Of the 146 patients, 64 (44%) had no movement disorder, 52 (36%) had one and 30 
(20%) more than one movement disorder (Table II).
Eighteen patients were receiving no antipsychotic medication at the time of 
assessment. Two (11%) had akathisia, 5 (20%) TD and 2 (11%) parkinsonism. The 
corresponding percentages for patients receiving antipsychotics were 19%, 29% and 
29%. Thus akathisia and parkinsonism but not TD were less common in those 
receiving no antipsychotics; the differences however were not statistically 
significant.
In addition to antipsychotic medication 37 patients were receiving antiparkinsonian 
medication, 18 antidepressants and 24 benzodiazepines. There were no significant 
differences in the prevalence of the three movement disorders betweeen those who 
were and were not receiving such drugs.
There were three principal types of neuroleptic prescribed - phenothiazines, 
thioxanthenes and substituted benzamides. Fewer patients taking benzamides alone 
had a movement disorder and/or were receiving antiparkinsonian medication (7 of
17, 41%) when compared with those taking phenothiazines (32 of 48, 67%) or
2
thioxanthenes (20 of 27, 74%) alone(x = 3.94, P < 0.05). Similar trends, not 
statistically significant, were found when benzamides (all oral) were compared with 
oral phenothiazines (only two patients were receiving an oral thioxanthene).
Dosage and plasma neuroleptic levels
The correlation (r) between dose and units of neuroleptic activity (UNA) in plasma 
in the 114 patients who gave a blood sample and who were receiving antipsychotic 
medication, was +0.43 (P < 0.001). The correlation in those receiving less than the 
equivalent of lOOOmg chlorpromazine daily (N = 103) was +0.08 (NS); for those 
receiving more than lOOOmg (N = 11) it was +0.72 (P < 0.01). In 42 patients the
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blood sample was taken either before the morning oral dose or the next longacting 
intra-muscular injection; the correlation between dose and UNA in these cases was 
+0.48 (P < 0.01).
Ninety eight patients who gave a blood sample were receiving a single neuroleptic. 
Comparisons between individual drugs could therefore be examined in this group. 
Results for 80 patients receiving the most commonly prescribed antipsychotics are 
shown in Table 4.4.3. Correlations between dose and UNA varied widely. The 
range was from +0.97 (chlorpromazine) to +0.14 (pimozide). A drug’s potency, that 
is, its ability to block dopamine D2 receptors, may be estimated by dividing UNA by 
dose; intra-muscular fluphenazine was the most, sulpiride the least potent (Table 
4.4.3).
The UNA: dose ratio was greater in those aged over 60 years (mean 1.61 (SD 3.04) 
vs 0.42 (0.60) t = 2.16 P < 0.05) and the correlation between potency and age was 
+0.28 (P < 0.01).
There were no significant differences in mean dose of neuroleptic, UNA and drug 
potency in those who did or did not have akathisia (patients with questionable and 
pseudo-akathisia were excluded) and did or did not have parkinsonism (Table 4.4.4). 
The latter finding also held good when those receiving antiparkinsonian medication 
were excluded. The mean dose and UNA in those with TD were significantly lower 
than those without TD (Table 4.4.4). However, the elderly were receiving less 
medication than younger age groups (eg. mean dose for those aged under 40 years, 
661mg (SD 791mg); 40-59 years, 405mg (409mg); 60 years and over, 200mg 
(131mg). When those aged over 60 were considered separately there was no 
difference between the probable and no TD groups in dosage, UNA and drug 
potency .
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It was possible to match 15 patients with and without akathisia for gender, hospital 
status and drug; 12 patients with and without parkinsonism for gender, age and drug; 
and 14 patients with and without TD for gender, age and drug. When the matched 
pairs were compared there were no significant between group differences in dosage, 
UNA or drug potency.
Additional medication
As reported above, some patients were prescribed other psychotropic medication in 
addition to neuroleptics; the three principal groups of drugs were antiparkinsonian 
medication, antidepressants and benzodiazepines. The mean UNA is those receiving 
and not receiving additional medication is shown in Table 4.4.5. The results suggest 
lower neuroleptic levels per unit dose when antiparkinsonian medication was added 
and higher levels when antidepressants were given; benzodiazepines had no effect.
Compliance
Below a level of 10 UNA, antipsychotics cannot be detected in plasma with the 
methods used in the present study. Of the 114 patients receiving antipsychotic 
medication who gave a blood sample, 55 were taking only oral antipsychotics. In 
five of these patients (9%) no neuroleptic could be detected in plasma. Although it is 
likely these five were non-compliant, in 11 patients receiving low doses of long 
acting intra-muscular medication no neuroleptic was detected. Three of the five 
patients were female; one was a day patient, two out patients and two were 
supervised by their general practitioner.
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DISCUSSION
The prevalence of akathisia in Nithsdale schizophrenic patients is 18%; to this figure 
can be added that for pseudoakathisia, 5%. The former figure is lower than that 
found in outpatients receiving intra-muscular medication (35 - 41%) (Barnes and 
Braude, 1985, Gibb and Lees, 1986). However, the present study included patients 
not receiving antipsychotic medication at the time of assessment. Akathisia was 
more common in inpatients and daypatients. It is possible that compliance with 
medication was better in inpatients and daypatients. Four of five patients who were 
probably non-compliant, as assessed by plasma neuroleptic levels, were outpatients 
or supervised only by their general practitioner. It may also be that some of the 
repetitive movements seen in longstay inpatients, such as rocking from foot to foot 
when standing, represent schizophrenic stereotypies rather than akathisia. However, 
this would not explain the inner sense of restlessness.
Previous work has found the association between akathisia and other movement 
disorders to be unclear. Acute akathisia, that it, akathisia occurring in patients where 
there has been a recent rise in antipsychotic drug dose, may be associated with severe 
parkinsonism, but not TD (Braude et al, 1983). Chronic akathisia, where there has 
been no recent change in drug dose, may be associated with both parkinsonism and 
TD (Friis et al, 1983, Barnes and Braude, 1985). In the present cross-sectional study, 
in which most patients probably had chronic akathisia, there was a statistically non­
significant association with parkinsonism and no association with TD. Four of the 
seven patients with pseudo-akathisia had TD of the trunk or extremities. This 
association may be genuine; however, distinguishing one from the other in an 
individual patient can be difficult.
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The prevalence of TD was 29%. This is broadly similar to that found in a recent 
survey (23.4%) which included subjects from three psychiatric facilities providing 
inpatient and outpatient care (Kane et al, 1988). Persistent TD, that is, TD found on 
all three examinations of 61 patients between 1981 and 1989, was present in only 
8%; of 14 patients with TD in 1981, only six had it in 1989. It is now well 
recognised that the presence and severity of TD can fluctuate over time (Gardos et al, 
1988, Yassa and Nair, 1989, Bergen et al, 1989). In the present study TD was 
associated with increasing age, the most consistent association found in TD research 
(Kane et al, 1988).
The prevalence of parkinsonism was 27% and it was more commonly found in the 
elderly. Antiparkinsonian medication was as commonly prescribed in those with 
parkinsonism as those without; the value of such medication given to patients 
receiving neuroleptics has long been questioned (Mindham et al, 1972).
Fewer patients receiving benzamides, when compared with those receiving 
phenothiazines or thioxanthenes had either a movement disorder or were receiving 
an antiparkinsonian drug.
The correlation between dose and UNA, a measure of plasma drug concentration, 
although statistically highly significant, was rather weak (r = +0.43). When only 
patients receiving less than the equivalent of lOOOmg. chlorpromazine daily were 
considered, it was negligible. This might be a chance finding, the radioreceptor 
technique might be less accurate at lower plasma neuroleptic levels, additional 
psychotropic medication might be a confounding variable (see below) or the 
conversion to chlorpromazine equivalents might have been inaccurate. The latter is 
unlikely as when individual drugs were examined, correlations in some drugs
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remained low. Lastly, poor or partial drug compliance might have contributed to the 
lack of correlation. The potency of individual drugs, as expressed by the ratio 
UNA:dose, in the main corresponded to clinical experience, with fluphenazine 
decanoate the most potent, and sulpiride the least. Thiordiazine was an exception. It 
was considerably more potent than chlorpromazine, whereas in clinical practice it is 
usually taken to be equipotent. Activity in plasma however may not accurately 
reflect activity in the brain.
Patients with akathisia or parkinsonism did not receive higher doses of antipsychotic 
drug nor had higher UNA than those without the movement disorder. A previous paper, 
referred to in the introduction (Hansen et al, 1982), suggested patients who develop 
extrapyramidal side effects (parkinsonism, akathisia and dystonia) had higher levels. 
Such patients however were in an acute phase of the illness and 50% had never received 
neuroleptic treatment before. In the present study probably individual susceptibility and 
pharmacodynamic changes in patients prescribed neuroleptics over lengthy periods are 
more important factors than plasma neuroleptic levels in determining whether or not 
patients develop parkinsonism or akathisia.
It has been suggested that TD is associated with high neuroleptic levels measured by the 
radioreceptor technique (Jeste et al, 1979) or fluorescence spectrophotometric assay 
(Yesavage et al, 1987). However, other studies using radioreceptor assay (Jeste et al, 
1981, Widerlov et al, 1982) failed to confirm this. Another study suggested a higher 
ratio of serum concentration to dose was found more often in TD patients (Jeste et al, 
1982) and suggested that abnormal metabolism of neuroleptics may be related to the 
pathophysiology of TD. In the present study, no association between TD and a high 
UNA or UNA: dose ratio was found when all patients of all ages were examined. On the 
contrary, patients with TD had a lower mean dose of neuroleptic and UNA. Age 
however was a confounding variable. The elderly who are more likely to develop TD
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were prescribed lower doses of medication. In patients aged over 60 years, the UNA: 
dose ratio was higher than in the under 60's, but in this age group also there was no 
relationship between UNA and UNA: dose ratio and TD. The present work therefore 
lends no support to those who have suggested TD is related to plasma neuroleptic levels.
The results suggest the addition of other psychotropic medication may influence plasma 
neuroleptic concentrations. In the present study patients receiving antiparkinsonian 
medication had lower neuroleptic levels. Previous work has produced conflicting results 
with some supporting the present finding (eg. Rivera-Calimlin et al, 1973, Logan et al, 
1975), others finding no effect (Simpson et al, 1980, El-Yousef and Manier, 1974), and 
others suggesting antiparkinson drugs increase levels (Kolakowska et al, 1976). 
Antidepressants appeared to raise neuroleptic levels. This is to be expected as 
neuroleptics and tricyclic antidepressants are known to require many of the same liver 
enzymes for their breakdown (Perel et al, 1974). Also, cross reaction of antidepressants 
in the radio-receptor assay cannot be ruled out. Amitriptyline and imipramine has been 
shown to cross react in caudate preparations with a potency of lA Vi that of thioridazine 
(Creese et al, 1981). Finally, benzodiazepines had no effect. This is in agreement with 
the finding that benzodiazepines do not affect the pharmacokentics of the tricyclic 
nortriptyline (Gram et al, 1973); since tricyclics and neuroleptics are degraded by the 
same metabolic route, benzodiazepines are also unlikely to affect plasma levels of 
neuroleptics.
Compliance with oral antipsychotic medication was probably high. In only 9% of 
patients taking oral drugs was antipsychotic medication not detected in plasma. 
Compliance of course is not an all-or-nothing phenomenon. Some patients may have 
been taking their medication only intermittently. Others in the community perhaps
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only restarted medication a day or two before their assessment; however, they were not 
aware before their appointment that a blood sample would be requested. Most Nithsdale 
schizophrenic patients have been in contact with local psychiatric services for many 
years. Most receive considerable support in the community; professionals from all 
disciplines stress the importance of maintenance antipsychotic therapy.
We conclude by emphasising the principal clinical finding, namely that only 44% of the 
146 patients had no movement disorder. This illustrates the urgent need for neuroleptics 
with fewer side effects. Seventy seven percent of all Nithsdale schizophrenic patients 
live outside hospital. Their acceptance by the community, already difficult, will not be 
improved by the fact that the majority have a disfiguring movement disorder.
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TABLE 4.4.1 
NITHSDALE SCHIZOPHRENIC PATIENTS 
DEMOGRAPHIC AND SOCIAL DATA
NUMBER OF PATIENTS (%)
SEX Male 75 (51)
Female 71 (49)
MARITAL Single 91 (62)
STATUS Married 27 (18)
Widowed 7 (5)
Divorced/Separated 20 (14)
Not known 1 (1)
HOSPITAL Inpatient 34 (23)
STATUS Daypatient 28 (19)
Outpatient 32 (22)
CPN supervision 29 (20)
GP supervision only 23 (16)
LENGTH OF HOSPITAL < 6 months 15 (44)
STAY: INPATIENTS 6 months < 1 year 2 (6 )
ONLY 1 < 5 years 4 (12)
5 < 10 years 2 (6 )
10 years + 11 (32)
LENGTH OF ILLNESS < 1 year 2 (1)
1 < 5 years 20 (14)
5 < 10 years 27 (18)
10 < 20 years 36 (25)
20 < 30 years 27 (19)
30 years + 34 (23)
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TABLE 4.4.2
PREVALENCE OF MOVEMENT DISORDERS
% (N = 146)
AKATHISIA
Absent 72
Questionable 10
Mild 13
Moderate 5
PSEUDOAKATHISIA
Absent 95
Present 5
TARDIVE DYSKINESIA
Absent 71
Probable 29
PARKINSONISM
Absent 73
Present 27
ANY MOVEMENT DISORDER
None 44
1 36
> 1 20
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TABLE 4.4.3
DOSAGE, UNITS OF NEUROLEPTIC ACTIVITY (UNA) 
AND POTENCY OF INDIVIDUAL DRUGS
DRUG NUMBER MEAN DOSE
OF mg/day
PATIENTS
ORAL
THIORIDAZINE 20 194
SULPIRIDE 12 567
PIMOZIDE 9 8
CHLORPROMAZINE 4 475
INTRAMUSCULAR
FLUPENTHIXOL 18 3.5
DECANOATE
FLUPHENAZINE 11 2.1
DECANOATE
HALOPERIDOL 6 3.8
DECANOATE
MEAN MEAN CORRELATION
UNA UNA/DOSE DOSE VS UNA 
(potency) 'r'
388 2.46 +0.67
56 0.10 +0.37
64 9.18 +0.14
211 0.43 +0.97
65 23.16 +0.44
56 28.54 +0.23
29 6.98 +0.81
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TABLE 4.4.4
DOSAGE, UNITS OF NEUROLEPTIC ACTIVITY (UNA) 
AND POTENCY OF DRUGS IN PATIENTS WITH AND 
WITHOUT MOVEMENT DISORDERS
AKATHISIA
Absent
Present
NUMBER OF MEAN 
PATIENTS DOSE,mg
(Standard 
Deviation)
78
22
365(394)
374(307)
MEAN
UNA
(Standard
Deviation)
131(186)
114(218)
MEAN UNA/ 
DOSE(potency) 
(Standard 
Deviation)
1.09(3.20)
0.54(1.16)
TARDIVE DYKINESIA 
Absent 81
Probable 33
*475(611)
*275(227)
**168(249) 
** 66(85)
0.74(1.39)
0.75(2.44)
PARKINSONISM
Absent
Present
81
33
376(385)
517(793)
144(218)
126(227)
0.86(1.97)
0.45(0.96)
* P < 0.02 
** P<0.01
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TABLE 4.4.5
DOSAGE, UNITS OF NEUROLEPTIC ACTIVITY (UNA) 
AND POTENCY OF DRUGS IN PATIENTS RECEIVING 
ANTIPSYCHOTIC MEDICATION AND ADDITIONAL 
PSYCHOTROPIC MEDICATION
NUMBER MEAN MEAN
OF DOSE OF UNA
PATIENTS NEUROLEPTIC
(mg)
(Standard (Standard
Deviation) Deviation)
MEAN
UNA/
DOSE
(potency)
(Standard
Deviation)
Antiparkinsonian
medication 37 614(808) 124(201) 0.39(0.83)
No antiparkinsonian 
medication 90 356(378) 147(229) 0.91(2.02)
Antidepressant
medication 18
*
265(174) 157(158) 1.75(3.51)
No antidepressant 
medication 110
*
459(580) 136(229) 0.58(1.21)
Benzodiazepines 24 459(878) 234(350) 0.80(0.96)
No Benzodiazepines 104 419(443) 119(177) 0.73(1.88)
1 patient not known
* P < 0.01
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OBSTETRIC COMPLICATIONS
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5.1 OBSTETRIC COMPLICATIONS, FAMILY HISTORY AND ABNORMAL
MOVEMENTS
ROBIN G McCREADIE 
DAVID J HALL 
IAN BERRY 
LESLEY J ROBERTSON 
JAMES I EWING 
MICHAEL F GEALS
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SUMMARY
Obstetric histories of 54 schizophrenic patients and 114 sibs were obtained from 
mothers and scored using the Obstetric Complications Scale of Lewis et al (1989). 
There was no statistically significant difference in the proportion of schizophrenic 
patients (35%) and sibs (29%) who had at least one definite obstetric complication. 
There was no evidence that schizophrenic patients with a history of obstetric 
complications were less likely to have a first degree relative with a history of 
psychiatric illness leading to inpatient care. Schizophrenic patients with a history of 
obstetric complications were more likely to have drug induced parkinsonism. There 
was a trend for tardive dyskinesia to be more common in those schizophrenic 
patients with no obstetric complications but a family history of schizophrenia.
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Most but not all studies have found an excess of obstetric complications in 
schizophrenic patients when compared with sibs, normal controls, or other patients 
(reviewed by Lewis, 1989). However, it is difficult to compare one study with 
another as they have used different control groups and different ways of assessing 
obstetric complications. For example, studies have compared schizophrenic patients 
with their sibs (DeLisi et al, 1987, Woemer et al, 1973, Lane and Albee, 1966, 
Eagles et al, 1990), with other patients (Pollack and Greenberg 1966, Lewis and 
Murray 1987) and with non-related controls (Jacobsen and Kinney 1980, Gillberg et 
al, 1986). Studies have obtained obstetric histories from records made at the time of 
birth (Lane and Albee 1966, Jacobsen and Kinney 1980, Gillberg et al, 1986, Eagles 
et al, 1990), retrospectively from mothers or other first degree relatives (DeLisi et al, 
1987, Pollack and Greenberg 1966), from both (Woemer et al, 1973) or from 
psychiatric records (Lewis and Murray 1987). All the above studies have shown an 
excess of obstetric complications in schizophrenic patients compared with the 
control group; however, the differences were in the main at a low level of statistical 
significance.
Other studies have not confirmed the excess of obstetric complications in 
schizophrenic patients. McNeil and Kaij (1978), examining birth records of 
schizophrenic patients and normal controls, found an excess of obstetric 
complications in patients with process schizophrenia, but not in those with 
schizophrenic-like psychosis. Parnas et al (1982), examining birth records of those 
bom to schizophrenic mothers found no statistically significant increase in obstetric 
complications in those who became schizophrenic when compared with those who 
did not; those with a diagnosis of borderline schizophrenia had fewer obstetric 
complications than normal off-spring. Turner et al (1986) in a computerised 
tomography study obtained histories from a parent or first degree relative and found
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no increased frequency of early physical trauma in young schizophrenic patients 
when compared with normal controls. Done et al (1990), examining birth records of 
all those born in the United Kingdom during one week in 1958 and tracing 
psychiatric records, found no excess of obstetric complications in schizophrenic 
patients when compared with normals. Many of the above studies examined 
hospitalised and presumably more severely ill schizophrenic patients.
The present study, the first of its kind, takes a broader view and examines obstetric 
complications in all known schizophrenic patients living within a discrete 
geographical area.
Tardive dyskinesia (TD) is more commonly found in schizophrenic patients with 
deficits in a variety of cognitive functions (Waddington et al, 1990). Obstetric 
complications might be one cause of such cerebral dysfunction and predispose to 
TD. However, a recent study found patients with TD were less likely to have 
experienced obstetric complications, and were more likely to have a family history of 
schizophrenia (O’Callaghan et al, 1990a). The second aim of the present study 
therefore is to examine further the relationship between obstetric complications, 
family history and movement disorders secondary to antipsychotic medication.
METHOD
The identification of schizophrenic patients has been described elsewhere 
(McCreadie, 1982a, McCreadie et al, 1991). Briefly, a repeat census on 11 
September 1989 in Nithsdale, South West Scotland, identified all known 
schizophrenic patients - inpatients, daypatients, outpatients, patients supervised by
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community psychiatric nurses and patients known only to their family doctor (N = 
165). Nineteen patients (12%) were excluded: 12 refused to participate, general 
practitioners refused access in a further three, and four were not approached (one 
patient was in a terminal care ward and three patients known only to their family 
doctor had refused to take part in previous Nithsdale surveys). Thus the study 
focused on 146 patients, 74% of whom fulfilled the DSM-III-R criteria for 
schizophrenia (American Psychiatric Association, 1987). Of these, 51% were male, 
49% female. Their mean age was 50 years (standard deviation 15, range 20-82).
Before 1977 birth records at the local maternity hospital were destroyed after seven 
years. The obstetric history of patients and their sibs was therefore obtained from 
patients' mothers, who with patients' consent were interviewed at home; such 
interviews took place as far afield as London and the north of Scotland. The 
interviews were conducted by one of two psychiatrists (DJH or IB) who at the start 
of the interview, with the principal exception of eight singletons, was in the majority 
of instances blind as to who was the patient, and who were his or her sibs. Mothers 
were asked not to reveal until the end of the interview the identity of the patient. 
Obstetric histories were obtained through a semi-structured interview developed in 
collaboration with a consultant obstetrician (MG) (Appendix). A third psychiatrist 
(JE), blind as to who were patients and sibs, scrutinised written answers to the semi- 
structured interview. He gave each a score using the Obstetric Complications Scale 
(Lewis et al, 1989). As suggested by Lewis and colleagues a person was categorised 
as having one or more definite complications, one or more equivocal but no definite 
complications, or no complications.
Mothers also gave information at the end of the interview about any admissions to 
psychiatric inpatient care of herself, her children, her childrens' father(s) and her
154
grandchildren. Case records were then obtained where a schizophrenic patient's sibs, 
parents or children had been admitted to a psychiatric hospital. References 
identifying the individual were deleted, and the third psychiatrist (JE) made a case 
record diagnosis using DSM-III-R criteria. To increase blindness, a number of case 
records of patients unrelated to the Nithsdale schizophrenic cohort were also 
included.
As described elsewhere (McCreadie et al, 1991) patients were assessed by one of 
two psychiatrists (RGMcC and U R ) for abnormal movements associated with 
antipsychotic medication. Both psychiatrists were blind to the obstetric history. TD 
was measured by the Abnormal Involuntary Movements Scale (US Department of 
Health, Education and Welfare 1976), parkinsonism by the Simpson and Angus 
Scale (Simpson and Angus, 1970) and akathisia by the Barnes Scale (Barnes 1989).
RESULTS
Of the 146 patients identified 61 (42%) had mothers who were alive. Three patients 
refused access to their mothers, and four mothers declined to be seen. Thus 51 
mothers of 54 patients were interviewed - one mother had two and another had three 
schizophrenic children among the original 146. The 54 patients had 114 sibs. The
patients whose mothers were interviewed differed from those whose mothers were
2
dead or were not interviewed in that they were younger (x = 35.20, P < 0.001) and
2 2 
had been ill a shorter time (x = 24.85, P < 0.001); fewer had TD (x = 4.34, P < 0.05)
2
or parkinsonism (x = 4.43, P < 0.05). When the schizophrenic patients about whom 
an obstetric history was obtained were compared with their sibs there was a trend, 
not statistically significant, for more of the former to be male (65% versus 48%).
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Significantly more were first born (41% vs 26%; x = 10.36, P < 0.01), but this 
difference disappeared when schizophrenic singletons (N = 8) were excluded.
Obstetric complications
There was no statistically significant difference in the proportion of schizophrenic 
patients and their sibs who had at least one definite complication (Table 5.1.1: 35% 
versus 29%); neither was there any difference in the total number of definite 
complications (Table 5.1.1). Further analyses failed to reveal any differences 
between schizophrenic patients and their sibs in total number of definite and 
equivocal complications, antepartum complications alone, intrapartum 
complications alone, mean maternal age at time of birth, and mean paternal age. 
There was no significant difference in the mean birth weight of schizophrenic 
patients whose mothers recalled an actual birth weight (N = 52) when compared with 
sibs (N = 106) (3.18kg (SD 0.51) vs 3.15 (0.58)). Inspection of the data showed no 
differences between schizophrenic patients and sibs in type of individual 
complication.
When only Nithsdale schizophrenic patients who fulfilled DSM-III-R criteria (N = 
38) were compared with their sibs, there was again no significant difference in the 
proportion with at least one definite obstetric complication (32% versus 27%).
A recent study (Eagles et al, 1990) compared schizophrenic patients with paired sibs. 
A paired sib was defined as the other sib in a sibship of two, a sib of the same sex in a 
sibship greater than two, and the sib closest in age if there were two or more sibs of 
the same sex. Forty four Nithsdale schizophrenic patients had a paired sib. Again 
there was no difference in the proportion with at least one definite obstetric 
complication (34% of schizophrenic patients versus 37% of sibs). The within-pair 
sign test failed to reveal any statistically significant differences when a comparison
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was made of those with and without at least one definite obstetric complication. In 
eight pairs the patient had an obstetric complication and the sib did not; in 11 pairs 
the sib had an obstetric complication and the patient did not. A within-pair 
comparison of those with and without a definite and/or an equivocal complication 
also failed to reveal any significant difference.
Assessment of family history (see below) identified a further four sibs who did not 
live in Nithsdale, but were schizophrenic. The figures were reanalysed (58 
schizophrenic patients and 110 sibs), but the result was essentially the same; 34% of 
schizophrenic patients and 29% of sibs had at least one definite obstetric 
complication. Finally, schizophrenic patients were compared with their sibs who 
had no history of any psychiatric illness leading to hospitalisation (58 schizophrenic 
patients and 106 sibs). Again no differences were found: 34% of schizophrenic 
patients and 28% of sibs had at least one definite obstetric complication.
Nithsdale schizophrenic patients with and without at least one definite obstetric 
complication were compared. There were no statistically significant differences 
between the two groups in sex, age, hospital status and age of onset and length of 
illness.
Family history
Twenty Nithsdale schizophrenic patients had first degree relatives who mothers said 
had been admitted to inpatient psychiatric care. Three brothers from one family and 
two brothers from another belonged to the Nithsdale cohort. The other 15 had 
relatives, either living outside Nithsdale with a psychiatric admission, or living in 
Nithsdale with an admission for an illness other than schizophrenia. DSM-III-R 
criteria applied to hospital case records showed a history of schizophrenia in first
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degree relatives of 10 Nithsdale schizophrenics, major depression in six, delusional 
disorder in two and bipolar disorder in one. One case record could not be traced and 
therefore 19 were considered to have a broadly defined family history of psychiatric 
illness. There was no statistically significant difference in sibship size between those 
who did and did not have a family history (mean 3.8 vs 3.0).
Obstetric complications and family history (Table 5.1.2)
There was no statistically significant difference between Nithsdale schizophrenic 
patients with (N = 19) and without (N = 35) a history of obstetric complications in 
the proportion with a broadly defined history of psychiatric illness (37% vs 34%). 
Similarly, when a narrow definition of a family history was used (DSM-III-R 
schizophrenia in a first degree relative) the proportion with a family history was not 
significantly different in those with and without a history of obstetric complications 
(16% vs 20%). A further analysis examined only Nithsdale schizophrenic patients 
with a DSM-III-R diagnosis of schizophrenia (N = 38). One of 12 patients with a 
definite obstetric complication (8%) and five of 26 with no complications (19%) had 
a family history of DSM-III-R schizophrenia leading to psychiatric admission, a 
statistically non-significant difference.
Obstetric complications and movement disorders
Patients, either with parkinsonism, defined as a score of more than 0.3 on the 
Simpson and Angus Scale (1970), or receiving an antiparkinsonian drug, more often
had a history of at least one definite obstetric complication than those with no
2
parkinsonism (58% versus 21%, x = 5.64, P < 0.02). There was a trend, not 
statistically significant, for fewer patients with TD (defined by the criteria of 
Schooler and Kane, 1982) to have a history of at least one obstetric complication 
when compared with those with no TD (1 of 9 (11%) versus 17 of 43 (40%)). There 
were no differences in obstetric complications in those with and without akathisia.
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Obstetric complications, tardive dyskinesia and family history 
None of 13 patients with at least one definite obstetric complication and no family 
history of psychiatric illness leading to inpatient care had TD; three out of 13 
patients with no definite obstetric complication but a family history had TD. One of 
16 patients with at least one definite obstetric complication and no family history of 
DSM-III-R schizophrenia had TD; three of seven patients with no definite obstetric 
complications but a family history of DSM-III-R schizophrenia had TD. Thus TD 
was associated with a family history of schizophrenia, but not with obstetric 
complications.
DISCUSSION
The present study has failed to demonstrate a difference between schizophrenic 
patients and their sibs in the proportion with a history of obstetric complications. 
Three other studies have used the same obstetric complications scale. Only one has 
used it in interviews with mothers (O'Callaghan et al, 1990a). It found a similar 
proportion of schizophrenic patients with at least one definite obstetric complication 
(33%); the obstetric history of sibs was not obtained. A second study applied the 
scale to birth records (Eagles et al, 1990 and personal communication); 70% of 
schizophrenic patients and 59% of normal siblings had at least one definite 
complication. A statistically significant difference between the two groups was only 
obtained when a cut-off point of two or more obstetric complications was used. This 
study probably examined those likely to have a complex or hazardous birth (Owen 
and McGuffin, 1990). The third study obtained information from psychiatric case 
records (Lewis and Murray, 1987). Seventeen percent of schizophrenic patients had 
definite obstetric complications compared with 8% of remaining patients;
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information about sibs was not obtained. It is likely information obtained solely 
from psychiatric records will underestimate the proportion of patients with 
complications.
In the present study every effort was made to obtain a full and objective history. 
Mothers were interviewed in the comfort of their own homes; during the interview 
the interviewers were for the most part blind as to who were patients and who were 
sibs; the interview was semi-structured, and therefore the same questions were 
asked about all sibs; and the final assessment of obstetric complications was made 
using the written replies, with the assessor blind to the patients' and sibs' identity. A 
criticism of the study might be that obstetric histories were obtained from mothers of 
patients. It is possible that the mother might have remembered better over the years 
the obstetric history of the future schizophrenic patient, particularly if there were 
childhood personality anomalies compared with siblings. If this were so it would 
magnify the importance of obstetric complications in patients with schizophrenia. 
This makes the result of the present study the more compelling. However, it has 
been shown recently, with the rating scale used in the present study, that there is a 
high level of agreement between mothers' histories and birth records (O'Callaghan et 
al, 1990b).
The present study has examined a community of schizophrenic patients, that is, all 
those known to be living in a discrete geographical area at a given moment in time, 
whether hospitalised or not. The population thus contains a number of patients who 
have had few admissions, and probably a better prognosis. However there was no 
difference between inpatients and non-inpatients in the proportion with obstetric 
complications.
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The present study is in agreement with the minority of previous studies (see 
introduction) which has failed to demonstrate a difference between schizophrenic 
patients and the comparison group. As stated previously studies which have found a 
difference have in the main done so at a low level of statistical significance. The 
most likely conclusion is that if there is an association between obstetric 
complications and schizophrenia it is a weak one.
It has been suggested that obstetric complications may be over-represented in 
schizophrenic cases which occur sporadically, and found less often in cases where 
there is a family history of schizophrenia (Murray et al, 1985); that is, obstetric 
complications and genetic predisposition are discrete aetiological factors. This view 
has been challenged (McGuffin et al, 1987) and not confirmed by Murray and 
colleagues (Nimgaonkar et al, 1988). However, a recent study has provided support 
for this hypothesis (O’Callaghan et al, 1990a); obstetric complications were more 
common in schizophrenic patients who did not have a family history of 
schizophrenia, affective disorder or suicide. In the present study where a rather 
similar broad definition of psychiatric illness was used, obstetric complications were 
as frequently found in those with as in those without a family history.
An unexpected finding was the association between obstetric complications and 
parkinsonism. We know of no other previous study that has reported this. Age was 
not a confounding factor as although parkinsonism was found more often with 
increasing age (McCreadie et al, 1991), a history of obstetric complications was not. 
By no means all patients given antipsychotic drugs develop parkinsonian side 
effects. Perhaps obstetric complications produce minimal brain damage which 
renders the brains of some schizophrenic patients more sensitive to neuroleptics.
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It has recently been suggested that patients with tardive dyskinesia are more likely to 
have a family history of psychiatric disorder (O'Callaghan et al, 1990a), a finding 
which suggests that genetic factors contribute not only to the aetiology of 
schizophrenia, but vulnerability to TD. In the present study numbers are small, but 
lend no support to this hypothesis when a family history of any psychiatric disorder 
among first degree relatives leading to inpatient care was considered. When a family 
history only of DSM-III-R schizophrenia was examined the trend was that TD 
occurred more often in those patients with no definite obstetric complications but a 
family history.
In conclusion, the present study has failed to confirm, firstly, an association between 
obstetric complications and schizophrenia, and, secondly, the separation of 
schizophrenic patients into those either with a family history or a history of obstetric 
complications, but not both.
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TABLE 5.1.1 
OBSTETRIC COMPLICATIONS
OBSTETRIC COMPLICATIONS SCHIZOPHRENIC SIBS
PATIENTS
% (N = 54) % (N = 114)
Absent 56 53
At least one equivocal
but no definite 9 18
complication
At least one definite
complication 35 29
TOTAL NUMBER OF 
DEFINITE COMPLICATIONS
0 65 71
1 18 19
2 9 6
3 8 3
4 -
5 - 1
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TABLE 5.1.2
OBSTETRIC COMPLICATIONS AND FAMILY HISTORY
FAMILY HISTORY * 
(broadly defined)
FAMILY HISTORY ** 
(narrowly defined)
NO FAMILY HISTORY
SCHIZOPHRENIC 
PATIENTS 
WITH OBSTETRIC 
COMPLICATIONS 
% (N = 19)
37
16
84
SCHIZOPHRENIC
PATIENTS
WITHOUT OBSTETRIC 
COMPLICATIONS 
% (N = 35)
34
66
20
80
NO FAMILY HISTORY 63
* Family history of schizophrenia (DSM-III-R 295) affective disorder 
(296) or delusional disorder (297) in first degree relative leading 
to psychiatric inpatient care.
** Family history of schizophrenia (DSM-III-R 295) in first degree 
relative leading to psychiatric inpatient care.
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APPENDIX
OBSTETRIC COMPLICATIONS QUESTIONNAIRE 
Numbers in brackets relate to numbered items on Obstetrics Complications Scale
(Lewis et al, 1989)
INTRODUCTION
Thank you for your co-operation. As you know from our letter, the purpose of my 
visit is to ask you a number of questions about your pregnancies and the births of 
your children. Although I am aware that member(s) of your family have had 
psychiatric problems, to allow me to remain completely objective, it would be 
helpful if you could attempt not to identify explicitly which family member this was.
I would like to work through the questions with you for each child, starting with the 
oldest.
Pregnancy
Firstly, regarding your pregnancy:
1(a) Were there any problems or complications that you remember? 
(1-4)
(b) Did you have to be admitted to hospital while you were pregnant?
(c) If so, why and for how long?
2 (a) Were any of the tests done at the ante-natal clinic abnormal? (1-2)
(b) Did they show up any previous infection?
(c) Did they detect any antibodies? (2)
(d) Did you have any infections while you were pregnant? (1)
(e) Did you have German measles or any sexually transmitted disease during 
pregnancy? (1)
(f) Did you receive antibiotic treatment? (1)
3.(a) Was there a problem with your blood pressure? (3)
(b) If so, did you have swelling of your ankles/fingers/ face? (3)
(c) Did you have a fit or fits during pregnancy? (3)
(d) Were you told that there was protein in your urine? (3)
(e) Did the problems with your blood pressure mean that you had to come 
into hospital for a period while you were pregnant? (3)
(f) Did they have to bring labour on early because of it? (3)
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4.(a) Did you have any vaginal bleeding during pregnancy?
(not just "spotting") (4)
(b) Did you have to go into hospital because of this?
(c) When, and for how long?
Delivery
Now, about the birth itself:
5.(a) How old were you when the baby was born?
(b) How old was the father?
(c) Boy or girl?
(d) Single or twin?
6.(a) If twin - how long was there between the two babies 
being born? (7)
(b) Who came first? (7)
(c) More that half an hour between them? (If yes = complicated delivery)
(d) Were both babies bom head first? (7) (If no = complicated delivery)
7.(a) Was the baby bom on time, early or late?
(b) Less than 37 weeks? (9)
(c) More than 42 weeks? (9)
8. Did you go into labour yourself or was the labour induced?
9. Was the baby lying correctly or not? If not, what was the problem? (11)
10.(a) How long was it between your waters breaking and the baby being born?
(b) Was it more than 24 hours? (5)
1 l.(a) How long was the labour?
(b) Less than 3 hours?
(c) More than 24 hours?
(d) More than 36 hours?
12. Would you say that the delivery was easy, normal or difficult? (6E)
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13.(a) Were forceps used in the delivery? (12)
(b) If so, did the baby have to be turned with the forceps? (12, if yes = 
difficult forceps delivery)
(c) Were you told that it was a difficult forceps delivery? (12)
14. Was the cord around the baby's neck or was it knotted? (8E)
15. Did the cord come down before the baby? (8D)
16.(a) Did you have a Caesarean Section? (10)
(b) Why was that done? (10)
(c) Was it an emergency or planned? (10)
17.(a) How much did the baby weigh? (13)
(b) Less than 5 lbs?
(c) Less than 4 lbs?
18. Was the baby all right or did it have to be revived? (probe if necessary) 
(14)
19.(a) Was the baby jaundiced?
(b) Was the baby treated for this?
20.(a) Did the baby have to go to an incubator?
(b) If so, for how long? More than 4 weeks? (14)
21. Were any physical abnormalities pointed out to you early on? (15)
END
Thank you for your cooperation.
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